The	O
cytoplasmic	B-protein
domain	I-protein
of	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	I-protein
GM-CSF	I-protein
)	I-protein
receptor	I-protein
alpha	I-protein
subunit	I-protein
is	O
essential	O
for	O
both	O
GM-CSF	B-protein
-mediated	O
growth	O
and	O
differentiation	O
.	O

Granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	O
GM-CSF	B-protein
)	O
regulates	O
differentiation	O
,	O
survival	O
,	O
and	O
proliferation	O
of	O
colony-forming	B-cell_line
unit-granulocyte-macrophage	I-cell_line
progenitor	I-cell_line
cells	I-cell_line
.	O

The	O
biologic	O
actions	O
of	O
GM-CSF	B-protein
are	O
mediated	O
by	O
binding	O
to	O
a	O
specific	O
receptor	O
consisting	O
of	O
two	O
chains	O
designated	O
as	O
alpha	B-protein
and	I-protein
beta	I-protein
subunits	I-protein
.	O

We	O
have	O
demonstrated	O
that	O
the	O
murine	B-cell_line
FDC-P1-derived	I-cell_line
cell	I-cell_line
line	I-cell_line
WT-19	B-cell_line
transfected	O
with	O
the	O
human	B-protein
GM-CSF	I-protein
receptor	I-protein
alpha	I-protein
and	I-protein
beta	I-protein
subunits	I-protein
(	O
GM-CSFRalpha	B-protein
and	I-protein
beta	I-protein
)	O
can	O
be	O
induced	O
to	O
differentiate	O
by	O
the	O
addition	O
of	O
human	B-protein
GM-CSF	I-protein
(	O
hGM-CSF	B-protein
)	O
.	O

By	O
expressing	O
a	O
series	O
of	O
GM-CSFRalpha	B-protein
mutants	I-protein
in	O
WT19	B-cell_line
cells	I-cell_line
,	O
we	O
have	O
determined	O
the	O
amino	B-protein
acid	I-protein
domains	I-protein
of	O
the	O
GM-CSFRalpha	B-protein
cytoplasmic	B-protein
domain	I-protein
that	O
regulate	O
cell	O
differentiation	O
,	O
proliferation	O
,	O
and	O
survival	O
.	O

We	O
found	O
that	O
the	O
membrane	B-protein
proximal	I-protein
proline-rich	I-protein
domain	I-protein
and	O
adjacent	B-protein
16	I-protein
residues	I-protein
are	O
essential	O
for	O
both	O
hGM-CSF	B-protein
-dependent	O
cell	O
proliferation	O
and	O
differentiation	O
.	O

In	O
contrast	O
,	O
the	O
C-terminal	B-protein
region	I-protein
of	O
the	O
GM-CSFRalpha	B-protein
cytoplasmic	I-protein
domain	I-protein
was	O
not	O
necessary	O
for	O
cell	O
differentiation	O
mediated	O
by	O
hGM-CSF	B-protein
,	O
but	O
the	O
removal	O
of	O
this	O
region	O
severely	O
impaired	O
the	O
ability	O
of	O
hGM-CSF	B-protein
to	O
support	O
cell	O
survival	O
.	O

While	O
the	O
activation	O
of	O
JAK2	B-protein
,	O
Shc	B-protein
,	O
Erk	B-protein
,	O
and	O
STAT5	B-protein
proteins	I-protein
correlated	O
with	O
hGM-CSF	B-protein
-mediated	O
cell	O
growth	O
,	O
cellular	O
differentiation	O
occurred	O
in	O
the	O
absence	O
of	O
activation	O
of	O
these	O
signal	O
transduction	O
pathways	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

28	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
11	NULL
,	NULL
pp	NULL
.	NULL

17450-17459	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

The	NULL
Cytoplasmic	NULL
Domain	NULL
of	NULL
Granulocyte-Macrophage	NULL
Colony-stimulating	NULL
Factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
Receptor	NULL
a	NULL
Subunit	NULL
Is	NULL
Essential	NULL
for	NULL
Both	NULL
GM-CSF-mediated	NULL
Growth	NULL
and	NULL
Differentiation*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
28	NULL
,	NULL
1997	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
from	NULL
,	NULL
May	NULL
19	NULL
,	NULL
1997	NULL
)	NULL
Tetsuya	NULL
Matsuguchi	NULL
$	NULL
#	NULL
$	NULL
§	NULL
,	NULL
Yanming	NULL
Zhao1	NULL
,	NULL
Michael	NULL
B.	NULL
Lilly	NULL
]	NULL
,	NULL
and	NULL
Andrew	NULL
S.	NULL
Kraft	NULL
$	NULL
#	NULL
**	NULL
From	NULL
the	NULL
{	NULL
Division	NULL
of	NULL
Medical	NULL
Oncology	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Science	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
University	NULL
of	NULL
Kentucky	NULL
,	NULL
Lexington	NULL
,	NULL
Kentucky	NULL
40536-0084	NULL
,	NULL
and	NULL
the	NULL
|Division	NULL
of	NULL
Medical	NULL
Oncology	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
and	NULL
Veterans	NULL
Administration	NULL
Medical	NULL
Center	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98108	NULL
Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
regulates	NULL
differentiation	NULL
,	NULL
survival	NULL
,	NULL
and	NULL
proliferation	NULL
of	NULL
colony-forming	NULL
unit-granulocyte-macrophage	NULL
progenitor	NULL
cells	NULL
.	NULL

The	NULL
biologic	NULL
actions	NULL
of	NULL
GM-CSF	NULL
are	NULL
mediated	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
specific	NULL
receptor	NULL
consisting	NULL
of	NULL
two	NULL
chains	NULL
designated	NULL
as	NULL
«	NULL
and	NULL
B	NULL
subunits	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
murine	NULL
FDC-P1-derived	NULL
cell	NULL
line	NULL
WT-19	NULL
transfected	NULL
with	NULL
the	NULL
human	NULL
GM-CSF	NULL
receptor	NULL
a	NULL
and	NULL
B	NULL
subunits	NULL
(	NULL
GM-CSFRa	NULL
and	NULL
$	NULL
)	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
human	NULL
GM-CSF	NULL
(	NULL
hGM-CSF	NULL
)	NULL
.	NULL

By	NULL
expressing	NULL
a	NULL
series	NULL
of	NULL
GM-CSFRa	NULL
mutants	NULL
in	NULL
WT19	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
the	NULL
amino	NULL
acid	NULL
domains	NULL
of	NULL
the	NULL
GM-CSFRa	NULL
cytoplasmic	NULL
domain	NULL
that	NULL
regulate	NULL
cell	NULL
differentiation	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
survival	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
membrane	NULL
proximal	NULL
proline-rich	NULL
domain	NULL
and	NULL
adjacent	NULL
16	NULL
residues	NULL
are	NULL
essential	NULL
for	NULL
both	NULL
hGM-CSF-dependent	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
the	NULL
GM-CSFRa	NULL
cytoplasmic	NULL
domain	NULL
was	NULL
not	NULL
necessary	NULL
for	NULL
cell	NULL
differentiation	NULL
mediated	NULL
by	NULL
hGM-CSF	NULL
,	NULL
but	NULL
the	NULL
removal	NULL
of	NULL
this	NULL
region	NULL
severely	NULL
impaired	NULL
the	NULL
ability	NULL
of	NULL
hGM-CSF	NULL
to	NULL
support	NULL
cell	NULL
survival	NULL
.	NULL

While	NULL
the	NULL
activation	NULL
of	NULL
JAK2	NULL
,	NULL
She	NULL
,	NULL
Erk	NULL
,	NULL
and	NULL
STATS	NULL
proteins	NULL
correlated	NULL
with	NULL
hGM-CSF-mediated	NULL
cell	NULL
growth	NULL
,	NULL
cellular	NULL
differentiation	NULL
occurred	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
activation	NULL
of	NULL
these	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
is	NULL
a	NULL
22-kDa	NULL
glycoprotein	NULL
,	NULL
which	NULL
is	NULL
secreted	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
fibroblasts	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
macrophages	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

GM-CSF	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
promoting	NULL
differentiation	NULL
,	NULL
survival	NULL
,	NULL
and	NULL
proliferation	NULL
of	NULL
colony-forming	NULL
unit-granulocyte-macrophage	NULL
progenitor	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
enhancing	NULL
the	NULL
function	NULL
of	NULL
mature	NULL
neutrophils	NULL
,	NULL
monocytes	NULL
,	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
DKA44741	NULL
(	NULL
to	NULL
A.	NULL
S.	NULL
K.	NULL
)	NULL
and	NULL
CA45672	NULL
(	NULL
to	NULL
M.	NULL
B.	NULL
L.	NULL
)	NULL
and	NULL
a	NULL
Veterans	NULL
Administration	NULL
Merit	NULL
Award	NULL
(	NULL
to	NULL
M.	NULL
B.	NULL
L.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Supported	NULL
by	NULL
direct	NULL
grants	NULL
from	NULL
the	NULL
University	NULL
of	NULL
Alabama	NULL
and	NULL
the	NULL
University	NULL
of	NULL
Colorado	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Division	NULL
of	NULL
Medical	NULL
Oncology	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Science	NULL
Center	NULL
,	NULL
4200	NULL
E.	NULL
Ninth	NULL
Ave.	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
80262	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
808-815-8802	NULL
;	NULL
Fax	NULL
:	NULL
803-815-8825	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
GM-CSFR	NULL
,	NULL
GM-CSF	NULL
receptor	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
;	NULL
MTS	NULL
,	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-yl	NULL
)	NULL
-5-	NULL
(	NULL
8-carboxymethoxyphenyl	NULL
)	NULL
-2-	NULL
(	NULL
4-sulfophenyl	NULL
)	NULL
-2H-tetrazolium	NULL
,	NULL
inner	NULL
salt	NULL
;	NULL
PMS	NULL
,	NULL
phenazine	NULL
methosulfate	NULL
;	NULL
FITC	NULL
,	NULL
fluorescein	NULL
isothiocyanate	NULL
;	NULL
FACS	NULL
,	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
;	NULL
MOPS	NULL
,	NULL
4-morpholinepropanesulfonic	NULL
acid	NULL
;	NULL
TBST	NULL
,	NULL
Tris-buffered	NULL
saline-T'ween	NULL
.	NULL

17450	NULL
and	NULL
eosinophils	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
and	NULL
stimulating	NULL
burst	NULL
promoting	NULL
activity	NULL
for	NULL
burst-forming	NULL
units	NULL
,	NULL
erythroid	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

GM-CSF	NULL
causes	NULL
a	NULL
major	NULL
cytoskeletal	NULL
reorganization	NULL
in	NULL
plasma	NULL
cells	NULL
and	NULL
hairy	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
motility	NULL
and	NULL
loss	NULL
of	NULL
adhesion	NULL
to	NULL
cellular	NULL
and	NULL
matrix	NULL
ligands	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
biologic	NULL
actions	NULL
of	NULL
GM-CSF	NULL
are	NULL
mediated	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
specific	NULL
receptor	NULL
consisting	NULL
of	NULL
a	NULL
and	NULL
B	NULL
subunits	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
members	NULL
of	NULL
the	NULL
type-I	NULL
cytokine	NULL
receptor	NULL
family	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

The	NULL
a	NULL
subunit	NULL
binds	NULL
GM-CSF	NULL
with	NULL
low	NULL
affinity	NULL
(	NULL
10	NULL
)	NULL
.	NULL

A	NULL
soluble	NULL
form	NULL
of	NULL
human	NULL
GM-CSF	NULL
receptor	NULL
«	NULL
subunit	NULL
(	NULL
GM-CSFRa	NULL
)	NULL
has	NULL
also	NULL
been	NULL
identified	NULL
,	NULL
whose	NULL
function	NULL
in	NULL
vivo	NULL
is	NULL
unclear	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

While	NULL
the	NULL
subunit	NULL
does	NULL
not	NULL
bind	NULL
GM-CSF	NULL
by	NULL
itself	NULL
,	NULL
it	NULL
forms	NULL
a	NULL
high	NULL
affinity	NULL
receptor	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
a	NULL
subunit	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
B	NULL
chain	NULL
is	NULL
called	NULL
the	NULL
common	NULL
$	NULL
chain	NULL
(	NULL
Bc	NULL
)	NULL
because	NULL
it	NULL
is	NULL
shared	NULL
by	NULL
interleukin	NULL
3	NULL
(	NULL
IL3	NULL
)	NULL
and	NULL
interleukin	NULL
5	NULL
(	NULL
IL5	NULL
)	NULL
receptors	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
GM-CSFRa	NULL
is	NULL
only	NULL
54	NULL
amino	NULL
acids	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
GM-CSFRa	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
necessary	NULL
for	NULL
GM-CSF-induced	NULL
cell	NULL
proliferation	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
showed	NULL
that	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
receptor	NULL
B	NULL
chain	NULL
(	NULL
GM-CSFR	NULL
$	NULL
)	NULL
is	NULL
also	NULL
essential	NULL
for	NULL
the	NULL
mitogenic	NULL
signal	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

However	NULL
,	NULL
because	NULL
of	NULL
the	NULL
lack	NULL
of	NULL
adequate	NULL
biologic	NULL
model	NULL
cell	NULL
systems	NULL
,	NULL
the	NULL
role	NULL
of	NULL
GM-CSFR	NULL
a	NULL
and	NULL
$	NULL
subunits	NULL
in	NULL
GM-CSF-induced	NULL
cell	NULL
differentiation	NULL
has	NULL
not	NULL
been	NULL
clearly	NULL
demonstrated	NULL
.	NULL

The	NULL
present	NULL
study	NULL
defines	NULL
the	NULL
role	NULL
of	NULL
GM-CSFRa	NULL
in	NULL
GM-CSF-mediated	NULL
differentiation	NULL
by	NULL
studying	NULL
WT19	NULL
cells	NULL
,	NULL
an	NULL
FDC-Pl-derived	NULL
cell	NULL
line	NULL
that	NULL
uniformly	NULL
differentiates	NULL
toward	NULL
the	NULL
monocytic	NULL
lineage	NULL
in	NULL
response	NULL
to	NULL
murine	NULL
GM-CSF	NULL
(	NULL
mGM-CSF	NULL
)	NULL
,	NULL
but	NULL
grows	NULL
and	NULL
does	NULL
not	NULL
differentiate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
murine	NULL
IL3	NULL
(	NULL
mIL3	NULL
)	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

We	NULL
find	NULL
that	NULL
when	NULL
the	NULL
wild	NULL
type	NULL
human	NULL
GM-CSFR	NULL
a	NULL
and	NULL
B	NULL
subunits	NULL
are	NULL
both	NULL
transfected	NULL
into	NULL
WT19	NULL
cells	NULL
,	NULL
these	NULL
cells	NULL
respond	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
human	NULL
GM-CSF	NULL
(	NULL
hGM-CSF	NULL
)	NULL
by	NULL
undergoing	NULL
differentiation	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
residues	NULL
of	NULL
GM-CSFRa	NULL
cytoplasmic	NULL
domain	NULL
necessary	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
cell	NULL
differentiation	NULL
,	NULL
WT1Q	NULL
cell	NULL
lines	NULL
were	NULL
established	NULL
which	NULL
express	NULL
mutated	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
the	NULL
a	NULL
subunit	NULL
along	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
B	NULL
subunit	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
GM-CSF	NULL
to	NULL
support	NULL
cell	NULL
survival	NULL
of	NULL
WTI9	NULL
correlated	NULL
with	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
,	NULL
STAT5	NULL
,	NULL
She	NULL
,	NULL
and	NULL
extracellular	NULL
signal-regulated	NULL
kinases	NULL
(	NULL
ERKs	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
differentiation	NULL
in	NULL
the	NULL
cells	NULL
containing	NULL
the	NULL
18-amino	NULL
acid	NULL
deletion	NULL
of	NULL
the	NULL
C-terminal	NULL
region	NULL
occurred	NULL
without	NULL
the	NULL
detectable	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
these	NULL
four	NULL
signaling	NULL
molecules	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
cell	NULL
survival	NULL
and	NULL
differentiation	NULL
are	NULL
controlled	NULL
by	NULL
different	NULL
signal	NULL
transduction	NULL
pathways	NULL
regulated	NULL
by	NULL
varying	NULL
portions	NULL
of	NULL
the	NULL
GM-CSFRae	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cells	NULL
and	NULL
Cell	NULL
Culture-WT1Q	NULL
is	NULL
a	NULL
cell	NULL
line	NULL
established	NULL
from	NULL
a	NULL
mouse	NULL
factor-dependent	NULL
myeloid	NULL
cell	NULL
line	NULL
,	NULL
FDC-P1	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GM-CSFR	NULL
«	NULL
-Chain	NULL
Mediates	NULL
Cell	NULL
Differentiation	NULL
17451	NULL
TaBLE	NULL
I	NULL
Differentiation	NULL
markers	NULL
of	NULL
WT19	NULL
cells	NULL
after	NULL
mIL3	NULL
and	NULL
mGM-CSF	NULL
stimulation	NULL
Morphology	NULL
Surface	NULL
markers	NULL
Staining	NULL
Cell	NULL
size	NULL
Granularity	NULL
F4/80	NULL
Macl	NULL
Mac3	NULL
Ngstigzzigc	NULL
(	NULL
21135222	NULL
phogaﬁgtas	NULL
e	NULL
IL3	NULL
+	NULL
+	NULL
+	NULL
-	NULL
+	NULL
-	NULL
-	NULL
GM-CSF	NULL
++	NULL
+++	NULL
+++	NULL
-	NULL
+++	NULL
+	NULL
-	NULL
+	NULL
Larry	NULL
Rohrschneider	NULL
,	NULL
Fred	NULL
Hutchinson	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
line	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
WEHI-3B	NULL
conditioned	NULL
medium	NULL
containing	NULL
mIL3	NULL
.	NULL

Reagents-Recombinant	NULL
hGM-CSF	NULL
was	NULL
purchased	NULL
from	NULL
Immunex	NULL
Corp.	NULL
(	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Recombinant	NULL
mGM-CSF	NULL
and	NULL
mIL3	NULL
were	NULL
obtained	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Site-directed	NULL
Mutagenesis	NULL
and	NULL
Construction	NULL
of	NULL
Expression	NULL
Plas-mids-The	NULL
human	NULL
GM-CSFRG	NULL
cDNA	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
plasmid	NULL
pKH97	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
A.	NULL
Miyajima	NULL
,	NULL
DNAX	NULL
Research	NULL
Institute	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
2.9-kilobase	NULL
pair	NULL
fragment	NULL
was	NULL
ligated	NULL
into	NULL
pCEP4	NULL
(	NULL
Invitrogen	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
hygromycin	NULL
selection	NULL
marker	NULL
giving	NULL
the	NULL
plasmid	NULL
pCEP4-GM-CSFRS	NULL
.	NULL

The	NULL
1.3-kilobase	NULL
pair	NULL
human	NULL
GM-CSF	NULL
receptor	NULL
a	NULL
chain	NULL
cDNA	NULL
was	NULL
removed	NULL
from	NULL
pCDMB8	NULL
vector	NULL
(	NULL
12	NULL
)	NULL
and	NULL
ligated	NULL
into	NULL
the	NULL
peDNA8	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
giving	NULL
the	NULL
plasmid	NULL
pCMV-GM-CSFRe	NULL
.	NULL

To	NULL
construct	NULL
GM-CSF	NULL
Ra	NULL
mutants	NULL
,	NULL
GM-CSFRa	NULL
cDNA	NULL
was	NULL
cloned	NULL
into	NULL
M13	NULL
mp19	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
a	NULL
kit	NULL
from	NULL
Amersham	NULL
,	NULL
using	NULL
oligonucleotides	NULL
:	NULL
GGGAACAGCCGTCATCACCTA-AGGAAC	NULL
(	NULL
ter1l	NULL
)	NULL
,	NULL
CTTTCCCTTCTCATCAGGTGAATTCCTC	NULL
(	NULL
ter8	NULL
)	NULL
,	NULL
CCTCATGGTTATCCCTAAGGAACCTT	NULL
(	NULL
dell	NULL
)	NULL
,	NULL
TCCCTTCCTCTGG-ATTCAGTTTGTCT	NULL
(	NULL
del2	NULL
)	NULL
,	NULL
GTCTTTGATCTGTATCCTAAGGAACC	NULL
(	NULL
del8	NULL
)	NULL
,	NULL
TGGAACTGGACCGAACAGC	NULL
(	NULL
P357G	NULL
)	NULL
,	NULL
TCTGTTCGTCAGTGT-GAAGATCAGAGC	NULL
(	NULL
P358G	NULL
)	NULL
,	NULL
CTTTGATCTGACCAACTGGCGG	NULL
(	NULL
P360G	NULL
)	NULL
.	NULL

The	NULL
mutated	NULL
cDNAs	NULL
were	NULL
isolated	NULL
and	NULL
ligated	NULL
into	NULL
pcDNA	NULL
vector	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
confirmed	NULL
by	NULL
restriction	NULL
enzyme	NULL
mapping	NULL
and	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

Isolations	NULL
of	NULL
WTI19	NULL
Transfectants-pCEP4-GM-CSFRB	NULL
was	NULL
introduced	NULL
into	NULL
WT19	NULL
cells	NULL
by	NULL
electroporation	NULL
at	NULL
260	NULL
V	NULL
,	NULL
975	NULL
microfarads	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
,	NULL
and	NULL
transfectants	NULL
isolated	NULL
using	NULL
hygromycin	NULL
(	NULL
0.4	NULL
mg/m	NULL
!	NULL

1	NULL
)	NULL
.	NULL

A	NULL
clone	NULL
termed	NULL
WT1Q	NULL
B1	NULL
expressing	NULL
was	NULL
used	NULL
for	NULL
the	NULL
transfection	NULL
of	NULL
pCMV-GM-CSFRa	NULL
wild-type	NULL
or	NULL
mutant	NULL
subunits	NULL
.	NULL

Resistant	NULL
clones	NULL
containing	NULL
the	NULL
a	NULL
subunit	NULL
were	NULL
then	NULL
isolated	NULL
using	NULL
G418	NULL
selection	NULL
(	NULL
0.4	NULL
mg/ml	NULL
)	NULL
.	NULL

Resulting	NULL
clones	NULL
were	NULL
screened	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
anti-human	NULL
GM-CSFRa	NULL
monoclonal	NULL
antibody	NULL
,	NULL
and	NULL
three	NULL
to	NULL
five	NULL
positive	NULL
clones	NULL
from	NULL
each	NULL
construct	NULL
were	NULL
expanded	NULL
for	NULL
further	NULL
studies	NULL
.	NULL

MTS	NULL
Cell	NULL
Proliferation	NULL
Assay-5,000	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
various	NULL
concentrations	NULL
of	NULL
hGM-CSF	NULL
for	NULL
14	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
atmosphere	NULL
.	NULL

20	NULL
ul	NULL
of	NULL
freshly	NULL
prepared	NULL
combined	NULL
8-	NULL
(	NULL
4,5-dimethylthiazol-2-yl	NULL
)	NULL
-5-	NULL
(	NULL
8-carboxyme-thoxyphenyl	NULL
)	NULL
-2-	NULL
(	NULL
4-sulfophenyl	NULL
)	NULL
-2H-tetrazolium	NULL
,	NULL
inner	NULL
salt/phenazine	NULL
methosulfate	NULL
(	NULL
MTS/PMS	NULL
)	NULL
solution	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
sample	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
4	NULL
h	NULL
of	NULL
incubation	NULL
at	NULL
87°C	NULL
,	NULL
the	NULL
conversion	NULL
of	NULL
MTS	NULL
into	NULL
the	NULL
aqueous	NULL
soluble	NULL
formazan	NULL
was	NULL
measured	NULL
at	NULL
an	NULL
absorbance	NULL
of	NULL
490	NULL
nm	NULL
.	NULL

Antibodies-Polyclonal	NULL
anti-human	NULL
anti-sera	NULL
were	NULL
prepared	NULL
using	NULL
a	NULL
glutathione	NULL
S-transferase	NULL
fusion	NULL
protein	NULL
containing	NULL
amino	NULL
acids	NULL
47-98	NULL
of	NULL
GM-CSFR	NULL
$	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
anti-phosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
4G10	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
anti-She	NULL
polyclonal	NULL
antibody	NULL
and	NULL
the	NULL
anti-STAT1	NULL
polyclonal	NULL
antibody	NULL
were	NULL
obtained	NULL
from	NULL
Signal	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

The	NULL
anti-STAT3	NULL
and	NULL
STATS5	NULL
polyclonal	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
STATS	NULL
antibody	NULL
(	NULL
sc-835	NULL
)	NULL
is	NULL
specific	NULL
for	NULL
both	NULL
STAT5a	NULL
and	NULL
STAT5b	NULL
.	NULL

The	NULL
anti-human	NULL
GM-CSFRa	NULL
monoclonal	NULL
antibody	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
A.	NULL
F.	NULL
Lopez	NULL
(	NULL
Instiute	NULL
of	NULL
Medical	NULL
and	NULL
Veterinary	NULL
Science	NULL
,	NULL
Adelaide	NULL
,	NULL
Australia	NULL
)	NULL
.	NULL

The	NULL
anti-Macl	NULL
and	NULL
Mac3	NULL
rat	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
anti-F4/80	NULL
rat	NULL
monoclonal	NULL
antibody	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
culture	NULL
su-pernatant	NULL
of	NULL
HB198	NULL
rat	NULL
hybridoma	NULL
cell	NULL
line	NULL
obtained	NULL
from	NULL
ATCC	NULL
.	NULL

Immunoblotting-Cells	NULL
were	NULL
lysed	NULL
in	NULL
PLC	NULL
buffer	NULL
(	NULL
50	NULL
my	NULL
HEPES	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
100	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
mM	NULL
NaPP	NULL
;	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
phenylmeth-anesulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
mg/ml	NULL
aprotinin	NULL
,	NULL
10	NULL
mg/ml	NULL
leupeptin	NULL
)	NULL
at	NULL
10°	NULL
cells/ml	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
separated	NULL
on	NULL
SDS-polyacrylamide	NULL
gels	NULL
,	NULL
elec-trotransferred	NULL
to	NULL
Immobilon	NULL
polyvinylidene	NULL
difluoride	NULL
membranes	NULL
(	NULL
Mil-lipore	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
blocked	NULL
for	NULL
2	NULL
h	NULL
in	NULL
2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin-TBST	NULL
(	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
0.15	NULL
M	NULL
sodium	NULL
chloride	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
,	NULL
incubated	NULL
with	NULL
primary	NULL
antibodies	NULL
in	NULL
TBST	NULL
for	NULL
1	NULL
h	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
TBST	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
horseradish	NULL
perox-idase-conjugated	NULL
anti-mouse	NULL
or	NULL
rabbit	NULL
immunoglobulin	NULL
(	NULL
Amersham	NULL
)	NULL
diluted	NULL
1:10,000	NULL
in	NULL
TBST	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
in	NULL
TBST	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
developed	NULL
with	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Immunoprecipitation-The	NULL
cell	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
antibody	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
followed	NULL
by	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
1	NULL
h.	NULL
The	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
PLC	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
then	NULL
suspended	NULL
in	NULL
SDS-sample	NULL
buffer	NULL
,	NULL
heated	NULL
at	NULL
95	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
eluted	NULL
proteins	NULL
were	NULL
applied	NULL
to	NULL
an	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
proteins	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-Total	NULL
cellular	NULL
RNAs	NULL
were	NULL
extracted	NULL
using	NULL
Trizol	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

15-pg	NULL
aliquots	NULL
of	NULL
the	NULL
total	NULL
RNAs	NULL
were	NULL
fractioned	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
20	NULL
mM	NULL
MOPS	NULL
,	NULL
5	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
and	NULL
6	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
formaldehyde	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
.	NULL

After	NULL
UV-cross-linking	NULL
,	NULL
membranes	NULL
were	NULL
soaked	NULL
in	NULL
prehy-bridization	NULL
solution	NULL
(	NULL
6	NULL
X	NULL
SSC	NULL
,	NULL
5	NULL
X	NULL
Denhardt	NULL
's	NULL
reagent	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
mg/ml	NULL
denatured	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
50	NULL
%	NULL
formamide	NULL
)	NULL
for	NULL
3	NULL
h	NULL
at	NULL
42	NULL
°C	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
*°P-labeled	NULL
probe	NULL
in	NULL
hybridization	NULL
solution	NULL
(	NULL
6	NULL
x	NULL
SSC	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
mg/ml	NULL
denatured	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
50	NULL
%	NULL
formamide	NULL
)	NULL
for	NULL
14	NULL
h	NULL
at	NULL
42	NULL
°C	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
washed	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
10	NULL
min	NULL
twice	NULL
at	NULL
room	NULL
temperature	NULL
;	NULL
in	NULL
0.1	NULL
X	NULL
SSC	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
10	NULL
min	NULL
twice	NULL
at	NULL
50	NULL
°C	NULL
;	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
films	NULL
.	NULL

hGM-CSF	NULL
Binding	NULL
Assay-hGM-CSF	NULL
binding	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
20	NULL
mm	NULL
Hepes	NULL
for	NULL
4	NULL
h	NULL
at	NULL
87	NULL
°C	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
RPMI	NULL
1640	NULL
+	NULL
2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
)	NULL
containing	NULL
varying	NULL
concentrations	NULL
of	NULL
'*°I-hGM-CSF	NULL
(	NULL
NEN	NULL
Life	NULL
Science	NULL
Prod-ucts	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

To	NULL
measure	NULL
nonspecific	NULL
binding	NULL
,	NULL
100-fold	NULL
excess	NULL
of	NULL
cold	NULL
hGM-CSF	NULL
was	NULL
added	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
centrifuged	NULL
through	NULL
a	NULL
phthalate	NULL
oil	NULL
layer	NULL
(	NULL
8:2	NULL
,	NULL
dioctyl	NULL
phthalate/di-n-butyl	NULL
phthalate	NULL
)	NULL
.	NULL

The	NULL
radioactivity	NULL
of	NULL
the	NULL
cell	NULL
pellet	NULL
was	NULL
counted	NULL
in	NULL
a	NULL
y	NULL
counter	NULL
.	NULL

The	NULL
binding	NULL
data	NULL
were	NULL
subjected	NULL
to	NULL
Scatchard	NULL
analysis	NULL
.	NULL

DNA	NULL
Fragmentation	NULL
Analysis-Before	NULL
lysis	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
hGM-CSF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
wash	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
cell	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
my	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
0.5	NULL
mg/ml	NULL
Proteinase	NULL
K	NULL
)	NULL
for	NULL
14	NULL
h	NULL
at	NULL
50	NULL
°C	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
3-h	NULL
incubation	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
0.25	NULL
mg/ml	NULL
RNase	NULL
,	NULL
the	NULL
genomic	NULL
DNA	NULL
was	NULL
extracted	NULL
with	NULL
phenol-chloroform	NULL
and	NULL
precipitated	NULL
with	NULL
ethanol	NULL
.	NULL

DNA	NULL
fragments	NULL
were	NULL
visualized	NULL
after	NULL
1.8	NULL
%	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
.	NULL

RESULTS	NULL
maM-CSF	NULL
Induces	NULL
Rapid	NULL
Monocytic	NULL
Differentiation	NULL
of	NULL
WT19	NULL
Cells	NULL
Which	NULL
Is	NULL
Reversible	NULL
after	NULL
Removal	NULL
of	NULL
the	NULL
Factor-WTIQ	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
growing	NULL
in	NULL
mIL-3	NULL
demonstrated	NULL
a	NULL
myeloblastic	NULL
morphology	NULL
including	NULL
rounded	NULL
nuclei	NULL
,	NULL
fine	NULL
chromatin	NULL
,	NULL
and	NULL
thin	NULL
and	NULL
basophilic	NULL
cytoplasm	NULL
.	NULL

In	NULL
response	NULL
to	NULL
mGM-CSF	NULL
,	NULL
the	NULL
cells	NULL
demonstrated	NULL
monocytic	NULL
characteristics	NULL
:	NULL
an	NULL
indented	NULL
nucleus	NULL
with	NULL
fine-stranded	NULL
appearance	NULL
,	NULL
increased	NULL
cytoplasm	NULL
containing	NULL
a	NULL
variable	NULL
number	NULL
of	NULL
vacuoles	NULL
,	NULL
and	NULL
larger	NULL
total	NULL
cell	NULL
size	NULL
.	NULL

Cells	NULL
treated	NULL
with	NULL
mGM-CSF	NULL
also	NULL
became	NULL
positive	NULL
for	NULL
nonspecific	NULL
esterase	NULL
and	NULL
acid	NULL
phosphatase	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

To	NULL
quantitate	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
undergoing	NULL
differentiation	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
mGM-CSF	NULL
or	NULL
mIL3	NULL
,	NULL
surface	NULL
marker	NULL
changes	NULL
were	NULL
evaluated	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

WTIQ	NULL
cells	NULL
growing	NULL
in	NULL
mIL3	NULL
showed	NULL
weak	NULL
surface	NULL
expression	NULL
of	NULL
F4/80	NULL
and	NULL
Mac3	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
monocytic	NULL
specific	NULL
markers	NULL
(	NULL
23-25	NULL
)	NULL
.	NULL

When	NULL
the	NULL
WTIQ	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
mGM-CSF	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
these	NULL
markers	NULL
was	NULL
significantly	NULL
increased	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
cells	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
17452	NULL
A	NULL
250	NULL
mil.3	NULL
miL3	NULL
-	NULL
>	NULL
mGM	NULL
day3	NULL
woo	NULL
mil3	NULL
-	NULL
>	NULL
m6M	NULL
day14	NULL
miL3	NULL
miL3	NULL
-	NULL
>	NULL
mGM	NULL
day3	NULL
«	NULL
-.-	NULL
_	NULL
miL3	NULL
~	NULL
>	NULL
»	NULL
mGM	NULL
day14	NULL
ase	NULL
--	NULL
--	NULL
-	NULL
NC	NULL
miL	NULL
3	NULL
«	NULL
--	NULL
-	NULL
mil3	NULL
~	NULL
>	NULL
mGM	NULL
day3	NULL
-~	NULL
-	NULL
mL3	NULL
-	NULL
>	NULL
ml	NULL
day14	NULL
a	NULL
To	NULL
tom	NULL
T	NULL
=T	NULL
19®	NULL
1a	NULL
}	NULL
102	NULL
102	NULL
F4/8B0	NULL
asa	NULL
.	NULL

mil3	NULL
{	NULL
R	NULL
miL3	NULL
-	NULL
>	NULL
mGM	NULL
day3	NULL
p	NULL
102	NULL
10	NULL
!	NULL

102	NULL
103	NULL
Mac3	NULL
GM-CSFR	NULL
«	NULL
-Chain	NULL
Mediates	NULL
Cell	NULL
Differentiation	NULL
B	NULL
ise	NULL
--	NULL
-	NULL
miL3	NULL
--	NULL
mil3	NULL
-	NULL
>	NULL
mGM	NULL
day	NULL
!	NULL

«	NULL
--	NULL
-	NULL
ml3	NULL
-	NULL
>	NULL
mGM	NULL
day2	NULL
-	NULL
~	NULL
-	NULL
-	NULL
mil3	NULL
-	NULL
>	NULL
»	NULL
m6M	NULL
days	NULL
--	NULL
-.-~	NULL
mil3	NULL
miL3	NULL
-	NULL
>	NULL
mGM	NULL
day1	NULL
«	NULL
«	NULL
-	NULL
mil3	NULL
-	NULL
>	NULL
>	NULL
mGM	NULL
day2	NULL
--	NULL
-	NULL
mil3	NULL
-	NULL
>	NULL
mGM	NULL
days	NULL
-_	NULL
mGM	NULL
--	NULL
-	NULL
mGM	NULL
-	NULL
>	NULL
mil3	NULL
day1	NULL
-.-	NULL
mGM	NULL
-	NULL
>	NULL
miL3	NULL
day2	NULL
-	NULL
-	NULL
-	NULL
_	NULL
m§M	NULL
-	NULL
>	NULL
mil3	NULL
day3	NULL
Fic	NULL
.	NULL

1.	NULL
mGM-CSF	NULL
induced	NULL
rapid	NULL
,	NULL
reversible	NULL
monocytic	NULL
differentiation	NULL
of	NULL
WT1Q	NULL
cells	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
WT19	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
factor-free	NULL
medium	NULL
and	NULL
then	NULL
were	NULL
placed	NULL
in	NULL
medium	NULL
containing	NULL
either	NULL
10	NULL
ng/ml	NULL
mIL3	NULL
or	NULL
mGM-CSF	NULL
.	NULL

Forward	NULL
(	NULL
FSC	NULL
)	NULL
and	NULL
side	NULL
scatter	NULL
(	NULL
SSC	NULL
)	NULL
parameters	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
examined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
monocyte	NULL
specific	NULL
F4/80	NULL
and	NULL
Mac3	NULL
was	NULL
examined	NULL
by	NULL
flow	NULL
cytometry	NULL
after	NULL
staining	NULL
with	NULL
the	NULL
appropriate	NULL
monoclonal	NULL
and	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-labeled	NULL
secondary	NULL
antibodies	NULL
.	NULL

The	NULL
control	NULL
WT1Q	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
the	NULL
secondary	NULL
antibody	NULL
alone	NULL
.	NULL

C	NULL
,	NULL
WT19	NULL
cells	NULL
maintained	NULL
in	NULL
medium	NULL
containing	NULL
10	NULL
ng/ml	NULL
mGM-CSF	NULL
were	NULL
washed	NULL
in	NULL
factor-free	NULL
medium	NULL
and	NULL
switched	NULL
to	NULL
medium	NULL
containing	NULL
mIL3	NULL
for	NULL
the	NULL
indicated	NULL
number	NULL
of	NULL
days	NULL
.	NULL

F4/80	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

differentiated	NULL
toward	NULL
monocytic	NULL
lineage	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
by	NULL
FACS	NULL
analysis	NULL
,	NULL
cell	NULL
size	NULL
and	NULL
granularity	NULL
also	NULL
increased	NULL
as	NULL
evidenced	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
both	NULL
forward	NULL
scattergram	NULL
(	NULL
FSC	NULL
)	NULL
and	NULL
side	NULL
scattergram	NULL
(	NULL
SSC	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

These	NULL
characteristics	NULL
were	NULL
stable	NULL
for	NULL
at	NULL
least	NULL
14	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Differentiated	NULL
cells	NULL
continued	NULL
to	NULL
divide	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
number	NULL
in-creased	NULL
.	NULL

Increases	NULL
in	NULL
both	NULL
F4/80	NULL
expression	NULL
and	NULL
cell	NULL
granularity	NULL
were	NULL
evident	NULL
within	NULL
1-2	NULL
days	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
mGM-CSF	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Washing	NULL
out	NULL
the	NULL
mGM-CSF	NULL
and	NULL
replacing	NULL
it	NULL
with	NULL
mIL3	NULL
caused	NULL
the	NULL
F4/80	NULL
expression	NULL
to	NULL
decrease	NULL
to	NULL
background	NULL
levels	NULL
within	NULL
3	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
mGM-CSF-induced	NULL
monocyte/macrophage	NULL
differentiation	NULL
of	NULL
WTI1Q	NULL
cells	NULL
is	NULL
a	NULL
reversible	NULL
phenomenon	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
mGM-CSF	NULL
induced	NULL
cell	NULL
differentiation	NULL
of	NULL
WTI19	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mIL3	NULL
,	NULL
suggesting	NULL
mGM-CSF-mediated	NULL
differentiation	NULL
signal	NULL
is	NULL
dominant	NULL
over	NULL
mIL3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

hGM-CSF	NULL
-induced	NULL
Differentiation	NULL
of	NULL
WT19	NULL
Cells	NULL
Transfected	NULL
with	NULL
Human	NULL
GM-CSF	NULL
Receptors-To	NULL
examine	NULL
the	NULL
ability	NULL
of	NULL
hGM-CSF	NULL
to	NULL
mediate	NULL
the	NULL
differentiation	NULL
of	NULL
WTIQ	NULL
cells	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
expression	NULL
plasmid	NULL
encoding	NULL
human	NULL
GM-CSFR	NULL
B	NULL
subunit	NULL
containing	NULL
a	NULL
hygromycin	NULL
resistance	NULL
se-lectable	NULL
marker	NULL
.	NULL

A	NULL
clone	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
GM-CSFR	NULL
$	NULL
,	NULL
WT19	NULL
$	NULL
clone	NULL
1	NULL
,	NULL
was	NULL
then	NULL
transfected	NULL
with	NULL
the	NULL
G418-selectable	NULL
expression	NULL
plasmid	NULL
encoding	NULL
GM-CSFRa	NULL
wild	NULL
type	NULL
subunit	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
further	NULL
selected	NULL
in	NULL
G418	NULL
.	NULL

Treatment	NULL
of	NULL
these	NULL
doubly	NULL
transfected	NULL
cells	NULL
with	NULL
hGM-CSF	NULL
induced	NULL
differentiation	NULL
of	NULL
WT19	NULL
cells	NULL
as	NULL
measured	NULL
by	NULL
changes	NULL
in	NULL
F4/80	NULL
and	NULL
Mac3	NULL
surface	NULL
markers	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
hGM-CSF-induce	NULL
differentiation	NULL
was	NULL
also	NULL
found	NULL
to	NULL
be	NULL
reversible	NULL
upon	NULL
removal	NULL
of	NULL
human	NULL
hGM-CSF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Human	NULL
GM-CSFRa	NULL
«	NULL
a	NULL
Mutants	NULL
in	NULL
WTI9	NULL
Cells-We	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
a	NULL
subunit	NULL
regulates	NULL
growth	NULL
of	NULL
factor-dependent	NULL
hematopoietic	NULL
cells	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Specific	NULL
residues	NULL
of	NULL
the	NULL
a	NULL
subunit	NULL
are	NULL
highly	NULL
conserved	NULL
among	NULL
growth	NULL
factor	NULL
receptors	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

As	NULL
hGM-CSF	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
the	NULL
differentiation	NULL
of	NULL
WTLQ	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
to	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
in	NULL
GM-CSF-mediated	NULL
cell	NULL
growth	NULL
,	NULL
survival	NULL
,	NULL
and	NULL
differentiation	NULL
.	NULL

A	NULL
series	NULL
of	NULL
expression	NULL
plasmids	NULL
encoding	NULL
deletion	NULL
and	NULL
substitution	NULL
mutants	NULL
of	NULL
GM-CSFRa	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
were	NULL
created	NULL
;	NULL
terl	NULL
mutant	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GM-CSFR	NULL
«	NULL
-Chain	NULL
Mediates	NULL
Cell	NULL
Differentiation	NULL
100	NULL
ase	NULL
A	NULL
wildtypej	NULL
P	NULL
teri	NULL
J	NULL
|	NULL
{	NULL
1a2	NULL
``	NULL
a°	NULL
18	NULL
!	NULL

1a	NULL
``	NULL
103	NULL
350	NULL
tera	NULL
deli	NULL
103	NULL
``	NULL
a°	NULL
182	NULL
100	NULL
del2	NULL
del3	NULL
1	NULL
|	NULL
|	NULL
10	NULL
!	NULL

102	NULL
103	NULL
``	NULL
a°	NULL
10	NULL
!	NULL

San-	NULL
“	NULL
1:3	NULL
200	NULL
100	NULL
P3STG	NULL
P358G	NULL
199	NULL
¥8	NULL
_	NULL
is	NULL
'	NULL
102	NULL
103	NULL
ase	NULL
[	NULL
~	NULL
;	NULL
same	NULL
F4/80	NULL
&	NULL
..	NULL
mIL3	NULL
miL3	NULL
-	NULL
>	NULL
hGM	NULL
day3	NULL
an	NULL
)	NULL
“	NULL
18	NULL
!	NULL

102	NULL
1:1	NULL
17453	NULL
B	NULL
ase	NULL
10	NULL
|	NULL
&	NULL
;	NULL
:	NULL
wild	NULL
type	NULL
A	NULL
tert	NULL
{	NULL
|	NULL
H	NULL
|	NULL
i	NULL
I	NULL
[	NULL
i	NULL
I	NULL
£	NULL
\	NULL
'	NULL
e°	NULL
vo	NULL
``	NULL
ee	NULL
18	NULL
``	NULL
”	NULL
la	NULL
?	NULL

Ch	NULL
ase	NULL
asa	NULL
|	NULL
ter3	NULL
|	NULL
;	NULL
dell	NULL
108	NULL
193	NULL
.	NULL

``	NULL
la	NULL
@	NULL
18	NULL
!	NULL

i182	NULL
18	NULL
?	NULL

ase	NULL
dela	NULL
|	NULL
***	NULL
del3	NULL
108	NULL
1a	NULL
!	NULL

102	NULL
¥E	NULL
102	NULL
18	NULL
!	NULL

122	NULL
103	NULL
ase	NULL
ase	NULL
&	NULL
P3S7ZG	NULL
P358G	NULL
em	NULL
“	NULL
lg	NULL
]	NULL
’	NULL
102	NULL
lg	NULL
:	NULL
10	NULL
``	NULL
10	NULL
'	NULL
‘	NULL
IE	NULL
’	NULL
1:2	NULL
aso	NULL
P360G	NULL
Mac3	NULL
...	NULL
...	NULL
mil	NULL
3	NULL
mil3	NULL
-	NULL
>	NULL
»	NULL
hGM	NULL
day3	NULL
em	NULL
“	NULL
lg	NULL
'	NULL
125	NULL
“	NULL
1:5	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Surface	NULL
expression	NULL
of	NULL
monocyte-specific	NULL
antigens	NULL
in	NULL
WT1Q	NULL
clones	NULL
treated	NULL
with	NULL
hGM-CSF	NULL
.	NULL

WTI	NULL
clones	NULL
were	NULL
maintained	NULL
in	NULL
mIL3	NULL
alone	NULL
or	NULL
mIL8	NULL
+	NULL
10	NULL
ng/ml	NULL
hGM-CSF	NULL
for	NULL
3	NULL
days	NULL
.	NULL

The	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
monocytic-specific	NULL
F4/80	NULL
(	NULL
A	NULL
)	NULL
and	NULL
Mac3	NULL
(	NULL
B	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
after	NULL
staining	NULL
with	NULL
the	NULL
respective	NULL
monoclonal	NULL
antibodies	NULL
and	NULL
FITC-labeled	NULL
secondary	NULL
antibodies	NULL
.	NULL

lacks	NULL
the	NULL
entire	NULL
cytoplasmic	NULL
domain	NULL
except	NULL
for	NULL
the	NULL
membrane-proximal	NULL
5	NULL
amino	NULL
acids	NULL
;	NULL
dell	NULL
has	NULL
an	NULL
internal	NULL
deletion	NULL
of	NULL
15	NULL
amino	NULL
acid	NULL
residues	NULL
corresponding	NULL
to	NULL
the	NULL
proline-rich	NULL
box	NULL
1	NULL
region	NULL
,	NULL
which	NULL
is	NULL
well	NULL
conserved	NULL
among	NULL
the	NULL
type	NULL
I	NULL
cytokine	NULL
receptor	NULL
family	NULL
;	NULL
del2	NULL
has	NULL
an	NULL
internal	NULL
16-amino	NULL
acid	NULL
deletion	NULL
adjacent	NULL
to	NULL
the	NULL
box	NULL
1	NULL
region	NULL
;	NULL
del3	NULL
has	NULL
an	NULL
8-amino	NULL
acid	NULL
deletion	NULL
within	NULL
the	NULL
box	NULL
1	NULL
region	NULL
removing	NULL
the	NULL
proline-rich	NULL
domain	NULL
(	NULL
PPVP	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
;	NULL
ter3	NULL
has	NULL
a	NULL
deletion	NULL
of	NULL
the	NULL
C-terminal	NULL
18	NULL
amino	NULL
acid	NULL
residues	NULL
;	NULL
and	NULL
three	NULL
individual	NULL
amino	NULL
acid	NULL
substitutions	NULL
have	NULL
mutations	NULL
in	NULL
the	NULL
well	NULL
conserved	NULL
proline-rich	NULL
do-main	NULL
:	NULL
proline	NULL
357	NULL
,	NULL
358	NULL
,	NULL
or	NULL
360	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

These	NULL
GM-CSFRa	NULL
expression	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
WT19	NULL
B	NULL
clone	NULL
1	NULL
,	NULL
and	NULL
the	NULL
G418-resistant	NULL
clones	NULL
were	NULL
isolated	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
mutants	NULL
were	NULL
analyzed	NULL
by	NULL
staining	NULL
with	NULL
a	NULL
specific	NULL
anti-GM-CSFRa	NULL
monoclonal	NULL
antibody	NULL
followed	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
with	NULL
a	NULL
FACScan	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

All	NULL
these	NULL
mutants	NULL
were	NULL
confirmed	NULL
to	NULL
express	NULL
Bc	NULL
equally	NULL
well	NULL
by	NULL
immunoblotting	NULL
using	NULL
specific	NULL
anti-GM-CSFRB	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Each	NULL
transfectant	NULL
was	NULL
examined	NULL
for	NULL
hGM-CSF	NULL
binding	NULL
using	NULL
*'*	NULL
``	NULL
I-labeled	NULL
hGM-CSF	NULL
,	NULL
and	NULL
the	NULL
results	NULL
of	NULL
high	NULL
affinity	NULL
binding	NULL
profiles	NULL
were	NULL
shown	NULL
in	NULL
Table	NULL
II	NULL
.	NULL

All	NULL
mutant	NULL
transfectants	NULL
including	NULL
terl	NULL
clones	NULL
bind	NULL
hGM-CSF	NULL
with	NULL
high	NULL
affinity	NULL
and	NULL
K	NULL
,	NULL
,	NULL
values	NULL
suggesting	NULL
that	NULL
there	NULL
are	NULL
equivalent	NULL
numbers	NULL
of	NULL
receptors	NULL
with	NULL
similar	NULL
affinity	NULL
.	NULL

These	NULL
results	NULL
sug-	NULL
gested	NULL
that	NULL
the	NULL
mutations	NULL
introduced	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
GM-CSFRa	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
interactions	NULL
of	NULL
GM-CSFRa	NULL
with	NULL
the	NULL
ligand	NULL
or	NULL
Multiple	NULL
Domains	NULL
of	NULL
GM-CSFRa	NULL
Are	NULL
Necessary	NULL
for	NULL
GM-CSF	NULL
induced	NULL
Protein-tyrosine	NULL
Phosphorylation	NULL
of	NULL
p52Shc	NULL
,	NULL
ERKs	NULL
,	NULL
JAK2	NULL
,	NULL
and	NULL
STAT5-It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
an	NULL
array	NULL
of	NULL
cytoplasmic	NULL
proteins	NULL
is	NULL
critical	NULL
for	NULL
cytokine	NULL
signal	NULL
transduction	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
spectrum	NULL
of	NULL
substrates	NULL
tyrosine-phosphorylated	NULL
by	NULL
addition	NULL
of	NULL
hGM-CSF	NULL
to	NULL
WTI9	NULL
cells	NULL
expressing	NULL
various	NULL
GM-CSFRa	NULL
mutants	NULL
.	NULL

Several	NULL
hematopoietic	NULL
cytokines	NULL
including	NULL
GM-CSF	NULL
induce	NULL
p52	NULL
She	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
which	NULL
correlates	NULL
with	NULL
their	NULL
ability	NULL
to	NULL
activate	NULL
Ras	NULL
(	NULL
26-30	NULL
)	NULL
.	NULL

GM-CSFRa	NULL
transfectants	NULL
were	NULL
assayed	NULL
for	NULL
hGM-CSF	NULL
-induced	NULL
She	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
anti-She	NULL
immunoprecipitation	NULL
followed	NULL
by	NULL
anti-phosphotyrosine	NULL
immunoblotting	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
increased	NULL
p52	NULL
She	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
wild	NULL
type	NULL
and	NULL
P357G	NULL
GM-CSFR	NULL
a	NULL
transfectants	NULL
but	NULL
not	NULL
in	NULL
the	NULL
other	NULL
mutants	NULL
.	NULL

Activated	NULL
Ras	NULL
through	NULL
a	NULL
cascade	NULL
of	NULL
protein	NULL
kinases	NULL
stimulates	NULL
phosphorylation	NULL
of	NULL
ERKs	NULL
(	NULL
31	NULL
)	NULL
.	NULL

hGM-CSF	NULL
induced	NULL
phosphorylation	NULL
of	NULL
both	NULL
p44ERK1	NULL
and	NULL
p42ERK2	NULL
in	NULL
wild	NULL
type	NULL
and	NULL
P357G	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
any	NULL
other	NULL
transfectants	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

GM-CSF	NULL
addition	NULL
to	NULL
cells	NULL
activates	NULL
JAK2	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
the	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
17454	NULL
A-	NULL
wr	NULL
_	NULL
CHT	NULL
]	NULL
keeuetort	NULL
twEEF	NULL
TPEEGKGYREEVLTVKETT*	NULL
tert	NULL
Cirrlue	NULL
dell	NULL
DNHEVEDET	NULL
TWEEFTPEEGKGYREEVLTVKETT*	NULL
del	NULL
2	NULL
KRFLRIQRLEPPVPQIKOKLN	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
PEEGKGYREEVLTVKEIT*®	NULL
del	NULL
3	NULL
KRFLRI	NULL
--	NULL
--	NULL
--	NULL
~-	NULL
QTIKDKLNDNHEVEDET	NULL
TWEEFTPERHKHYREEVL	NULL
TVKETT®*	NULL
ter3	NULL
|	NULL
P3576	NULL
.	NULL

KRFLRTIQRL	NULL
FGPVPQTKDKLNDNHEVEDET	NULL
TWEEF	NULL
TPEEGKGYREEVLTVKET	NULL
T*	NULL
P358	NULL
6G	NULL
-	NULL
[	NULL
CTM	NULL
TVKETT*	NULL
[	NULL
CPM	NULL
--	NULL
-	NULL
]	NULL
KRFLRTIQRLFPPVGOTKDKLNDNHEVEDETIWEEFTPEEGKGYREEVLTVKETT*	NULL
B	NULL
GM-CSFRe	NULL
IL	NULL
5Re	NULL
:	NULL
PRLR	NULL
GHR	NULL
IL6Ra	NULL
G-CSFR	NULL
LIFR	NULL
GP130	NULL
EPOR	NULL
yC	NULL
IL7/Ra	NULL
MPLR	NULL
TL3Ra	NULL
IL2Rp	NULL
IL4Ra	NULL
pc	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

GM-CSFRa	NULL
cytoplasmic	NULL
domain	NULL
mutants	NULL
.	NULL

A	NULL
,	NULL
deleted	NULL
amino	NULL
acid	NULL
residues	NULL
are	NULL
indicated	NULL
as	NULL
dashes	NULL
.	NULL

Amino	NULL
acid	NULL
substitutions	NULL
are	NULL
indicated	NULL
by	NULL
underlines	NULL
and	NULL
boldface	NULL
type	NULL
.	NULL

B	NULL
,	NULL
comparison	NULL
of	NULL
the	NULL
amino	NULL
acid	NULL
sequences	NULL
conserved	NULL
among	NULL
the	NULL
cytokine	NULL
receptor	NULL
family	NULL
.	NULL

The	NULL
proline-rich	NULL
regions	NULL
of	NULL
various	NULL
cytokine	NULL
receptor	NULL
cytoplasmic	NULL
domains	NULL
are	NULL
shown	NULL
.	NULL

Conserved	NULL
prolines	NULL
are	NULL
boxed	NULL
.	NULL

m	NULL
©	NULL
ml	NULL
u	NULL
cu	NULL
u	NULL
co	NULL
Uu	NULL
UTU	NULL
CU	NULL
IU	NULL
UCU	NULL
2	NULL
m	NULL
mu	NULL
m	NULL
ozo	NULL
cv	NULL
tu	NULL
CU	NULL
Hoe	NULL
4	NULL
mom	NULL
Hk	NULL
€	NULL
H	NULL
t	NULL
cc	NULL
<	NULL
aca	NULL
z	NULL
[	NULL
o	NULL
1	NULL
v	NULL
v	NULL
uu	NULL
vv	NULL
uu	NULL
vu	NULL
uuu	NULL
ul	NULL
z	NULL
4	NULL
0T	NULL
00-4152	NULL
0m	NULL
<	NULL
armo	NULL
-	NULL
[	NULL
ev	NULL
eye	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STATS	NULL
(	NULL
32-34	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
and	NULL
STAT5	NULL
was	NULL
induced	NULL
by	NULL
GM-CSF	NULL
in	NULL
wild	NULL
type	NULL
and	NULL
P357G	NULL
mutants	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

On	NULL
shorter	NULL
exposure	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
two	NULL
STATS	NULL
iso-forms	NULL
(	NULL
STATS	NULL
a	NULL
and	NULL
b	NULL
)	NULL
was	NULL
observed	NULL
.	NULL

A	NULL
slight	NULL
decrease	NULL
in	NULL
JAK2	NULL
and	NULL
STAT5	NULL
phosphorylation	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
in	NULL
the	NULL
P357G	NULL
transfectants	NULL
was	NULL
not	NULL
constantly	NULL
reproducible	NULL
.	NULL

In	NULL
the	NULL
other	NULL
GM-CSFRa	NULL
mutant	NULL
cell	NULL
lines	NULL
,	NULL
GM-CSF	NULL
did	NULL
not	NULL
induce	NULL
detectable	NULL
JAK2	NULL
or	NULL
STATS	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Activation	NULL
of	NULL
STATS	NULL
in	NULL
wild-type	NULL
and	NULL
P357G	NULL
GM-CSFRa	NULL
transfectants	NULL
was	NULL
also	NULL
detected	NULL
by	NULL
gel	NULL
shift	NULL
assay	NULL
using	NULL
y-interferon-activated	NULL
site	NULL
of	NULL
the	NULL
IRF-1	NULL
promoter	NULL
and	NULL
anti-STAT5	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicated	NULL
that	NULL
the	NULL
same	NULL
regions	NULL
of	NULL
GM-CSFRa	NULL
that	NULL
are	NULL
essential	NULL
for	NULL
GM-CSF-induced	NULL
Shc-ERK	NULL
phosphorylation	NULL
are	NULL
also	NULL
essential	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
JAK2	NULL
and	NULL
STATS	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Protooncogene	NULL
Expression	NULL
in	NULL
GM-CSFRa	NULL
Transfectants-GM-CSF	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
rapid	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
protooncogenes	NULL
,	NULL
including	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
c-myc	NULL
(	NULL
29	NULL
,	NULL
35	NULL
)	NULL
.	NULL

In	NULL
wild-type	NULL
GM-CSFRa	NULL
and	NULL
the	NULL
P357G	NULL
transfectants	NULL
,	NULL
expression	NULL
of	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
e-mye	NULL
mRNAs	NULL
was	NULL
rapidly	NULL
induced	NULL
upon	NULL
hGM-CSF	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
was	NULL
not	NULL
induced	NULL
in	NULL
the	NULL
other	NULL
a	NULL
subunit	NULL
mutants	NULL
except	NULL
ter3	NULL
.	NULL

In	NULL
ter3	NULL
mutant	NULL
receptor	NULL
cell	NULL
lines	NULL
,	NULL
hGM-CSF	NULL
was	NULL
capable	NULL
of	NULL
inducing	NULL
c-jun	NULL
but	NULL
not	NULL
c-fos	NULL
mRNA	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
induction	NULL
of	NULL
c-mye	NULL
mRNA	NULL
expression	NULL
was	NULL
repeatedly	NULL
observed	NULL
in	NULL
both	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
all	NULL
of	NULL
the	NULL
mutant	NULL
clones	NULL
,	NULL
indicating	NULL
that	NULL
hGM-CSF	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
c-mye	NULL
mRNA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
GM-CSFRa	NULL
cytoplasmic	NULL
domain	NULL
and	NULL
that	NULL
all	NULL
of	NULL
the	NULL
mutant	NULL
receptors	NULL
are	NULL
capable	NULL
of	NULL
signaling	NULL
.	NULL

The	NULL
Cytoplasmic	NULL
Domain	NULL
of	NULL
GM-CSFRa	NULL
Is	NULL
Critical	NULL
for	NULL
GM-CSF-mediated	NULL
Cell	NULL
Proliferation-We	NULL
next	NULL
examined	NULL
hGM-CSF-induced	NULL
cell	NULL
proliferation	NULL
of	NULL
WT1Q	NULL
transfectants	NULL
expressing	NULL
a	NULL
chain	NULL
mutants	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
both	NULL
the	NULL
wild	NULL
type	NULL
GM-CSFRa	NULL
transfectant	NULL
and	NULL
the	NULL
P357G	NULL
mutant	NULL
proliferated	NULL
upon	NULL
addition	NULL
of	NULL
hGM-CSF	NULL
to	NULL
the	NULL
medium	NULL
.	NULL

terl	NULL
,	NULL
dell	NULL
,	NULL
del2	NULL
,	NULL
del3	NULL
,	NULL
P358G	NULL
,	NULL
and	NULL
P360G	NULL
did	NULL
not	NULL
show	NULL
any	NULL
proliferative	NULL
response	NULL
to	NULL
hGM-CSF	NULL
,	NULL
suggesting	NULL
that	NULL
some	NULL
residues	NULL
of	NULL
the	NULL
«	NULL
GM-CSFR	NULL
«	NULL
-Chain	NULL
Mediates	NULL
Cell	NULL
Differentiation	NULL
«	NULL
ea	NULL
T	NULL
200	NULL
-	NULL
parental	NULL
IA	NULL
wild	NULL
type	NULL
1	NULL
4	NULL
J	NULL
|	NULL
I	NULL
4	NULL
1	NULL
i	NULL
1	NULL
fA	NULL
|	NULL
|	NULL
J	NULL
A	NULL
c	NULL
,	NULL
+4	NULL
-me	NULL
itn	NULL
rem-rn	NULL
a	NULL
rem	NULL
188	NULL
0	NULL
ca	NULL
?	NULL

i828	NULL
0	NULL
0	NULL
co	NULL
``	NULL
102	NULL
_	NULL
ae	NULL
!	NULL

102	NULL
0	NULL
ae	NULL
``	NULL
1a	NULL
``	NULL
F1TC	NULL
FLUORESCENCE	NULL
rite	NULL
rcuoregscence	NULL
120	NULL
200	NULL
teri	NULL
1	NULL
A	NULL
w	NULL
-	NULL
tor3	NULL
A\	NULL
i	NULL
11	NULL
}	NULL
UU	NULL
JO	NULL
X	NULL
%	NULL
Abes	NULL
,	NULL
}	NULL
as	NULL
fo	NULL
``	NULL
Coig	NULL
mieten	NULL
_	NULL
weo	NULL
10	NULL
!	NULL

108	NULL
103	NULL
10	NULL
``	NULL
l	NULL
a	NULL
a	NULL
10	NULL
19	NULL
ite	NULL
ruuomescente	NULL
fife	NULL
«	NULL
20	NULL
zon	NULL
R	NULL
f	NULL
del2	NULL
|	NULL
A	NULL
deli	NULL
|	NULL
A	NULL
\	NULL
(	NULL
\	NULL
f	NULL
|	NULL
$	NULL
4	NULL
{	NULL
}	NULL
ee	NULL
Io	NULL
}	NULL
}	NULL
Po	NULL
A	NULL
T	NULL
Fi	NULL
-m	NULL
-	NULL
io	NULL
!	NULL

let	NULL
0	NULL
ie	NULL
``	NULL
it	NULL
0	NULL
188	NULL
0	NULL
da	NULL
'	NULL
fa2	NULL
0	NULL
ial	NULL
a+	NULL
FITC	NULL
FLUORESCENCE	NULL
FITC	NULL
FLuoRescence	NULL
lao	NULL
200	NULL
del3	NULL
Pasra	NULL
___	NULL
_.-~	NULL
m	NULL
®	NULL
102	NULL
10	NULL
!	NULL

102	NULL
102	NULL
18	NULL
*	NULL
18	NULL
ch	NULL
ine	NULL
183	NULL
ch	NULL
FITC	NULL
FLUORESCENCE	NULL
FITC	NULL
Fluorescence	NULL
100	NULL
100	NULL
Passa	NULL
P360G	NULL
I	NULL
If	NULL
|	NULL
rem	NULL
0	NULL
a	NULL
102	NULL
te	NULL
!	NULL

102	NULL
103	NULL
10+	NULL
he	NULL
1g	NULL
'	NULL
102	NULL
183	NULL
G	NULL
FITC	NULL
FLUORESCENCE	NULL
FITC	NULL
FLUORESCENCE	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
GM-CSFRa	NULL
expression	NULL
on	NULL
WT19	NULL
transfectants	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
either	NULL
anti-GM-CSFRa	NULL
monoclonal	NULL
antibody	NULL
followed	NULL
by	NULL
FITC-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
or	NULL
with	NULL
FITC-conjugated	NULL
anti-mouse	NULL
IgG	NULL
alone	NULL
.	NULL

chain	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
indispensable	NULL
for	NULL
hGM-CSF-mediated	NULL
growth	NULL
signal	NULL
transduction	NULL
.	NULL

These	NULL
studies	NULL
confirm	NULL
our	NULL
earlier	NULL
findings	NULL
about	NULL
the	NULL
role	NULL
of	NULL
GM-CSFRa	NULL
cytoplasmic	NULL
domain	NULL
in	NULL
promoting	NULL
growth	NULL
of	NULL
BaF/3	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
ter	NULL
clones	NULL
that	NULL
lack	NULL
the	NULL
C-terminal	NULL
18	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
a	NULL
chain	NULL
with	NULL
hGM-CSF	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
cell	NULL
numbers	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
cells	NULL
died	NULL
,	NULL
but	NULL
more	NULL
slowly	NULL
than	NULL
terl	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

In	NULL
MTS	NULL
cell	NULL
proliferation	NULL
as-says	NULL
,	NULL
ter3	NULL
clones	NULL
clearly	NULL
showed	NULL
hGM-CSF-mediated	NULL
cell	NULL
proliferation	NULL
signal	NULL
,	NULL
although	NULL
it	NULL
was	NULL
weaker	NULL
than	NULL
wild	NULL
type	NULL
or	NULL
P357G	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Cell	NULL
death	NULL
in	NULL
factor-dependent	NULL
cells	NULL
is	NULL
known	NULL
to	NULL
occur	NULL
through	NULL
apoptotic	NULL
mechanisms	NULL
.	NULL

To	NULL
examine	NULL
if	NULL
apoptosis	NULL
occurred	NULL
in	NULL
ter3	NULL
cell	NULL
number	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hGM-CSF	NULL
,	NULL
genomic	NULL
DNA	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
chain	NULL
transfectants	NULL
incubated	NULL
with	NULL
hGM-CSF	NULL
and	NULL
DNA	NULL
fragmentation	NULL
was	NULL
analyzed	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

ter3	NULL
showed	NULL
detectable	NULL
DNA	NULL
fragmentation	NULL
characteristic	NULL
of	NULL
apoptosis	NULL
by	NULL
9	NULL
h	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GM-CSFR	NULL
«	NULL
-Chain	NULL
Mediates	NULL
Cell	NULL
Differentiation	NULL
and	NULL
showed	NULL
pronounced	NULL
apoptosis	NULL
by	NULL
24	NULL
h	NULL
after	NULL
withdrawal	NULL
of	NULL
mIL3	NULL
and	NULL
the	NULL
addition	NULL
of	NULL
hGM-CSF	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
ter3	NULL
mutants	NULL
that	NULL
are	NULL
able	NULL
to	NULL
transduce	NULL
a	NULL
cell	NULL
proliferation	NULL
signal	NULL
by	NULL
GM-CSF	NULL
have	NULL
severely	NULL
impaired	NULL
anti-apoptotic	NULL
signaling	NULL
.	NULL

hGM-CSF	NULL
-induced	NULL
Monocytic	NULL
Differentiation	NULL
of	NULL
WTI19	NULL
Cells	NULL
Expressing	NULL
hGM-CSF	NULL
Receptors-Next	NULL
we	NULL
analyzed	NULL
hGM-CSF-induced	NULL
differentiation	NULL
of	NULL
WTI1Q	NULL
cells	NULL
expressing	NULL
human	NULL
GM-CSFRa	NULL
.	NULL

All	NULL
the	NULL
a	NULL
subunit	NULL
transfectants	NULL
examined	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
differentiate	NULL
when	NULL
mGM-CSF	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
several	NULL
transfectants	NULL
died	NULL
within	NULL
24	NULL
h	NULL
after	NULL
the	NULL
withdrawal	NULL
of	NULL
mIL3	NULL
,	NULL
cell	NULL
lines	NULL
were	NULL
II	NULL
Binding	NULL
profiles	NULL
of	NULL
GM-CSF	NULL
on	NULL
WT19	NULL
transfectants	NULL
Two	NULL
to	NULL
four	NULL
clones	NULL
were	NULL
analyzed	NULL
for	NULL
each	NULL
mutant	NULL
.	NULL

Mean	NULL
K	NULL
,	NULL
,	NULL
value	NULL
is	NULL
shown	NULL
.	NULL

High	NULL
affinity	NULL
receptor	NULL
No	NULL
.	NULL

of	NULL
bindin	NULL
K4	NULL
sites/cell	NULL
l	NULL
pM	NULL
Wild	NULL
type	NULL
120	NULL
930-1,600	NULL
terl	NULL
56	NULL
600-1,100	NULL
dell	NULL
110	NULL
500-1,850	NULL
del2	NULL
102	NULL
500-1,600	NULL
del8	NULL
67	NULL
970-1,500	NULL
ters	NULL
50	NULL
1,000-2,000	NULL
P357G	NULL
105	NULL
1,200-1,600	NULL
P358G	NULL
87	NULL
BOO—1,600	NULL
P360G	NULL
73	NULL
400-900	NULL
terl	NULL
wt	NULL
W	NULL
race	NULL
aShcIP	NULL
aP-Tyr	NULL
sie	NULL
«	NULL
ite	NULL
blot	NULL
17455	NULL
treated	NULL
with	NULL
hGM-CSF	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
mIL3	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
hGM-CSF	NULL
for	NULL
3	NULL
days	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
examined	NULL
for	NULL
monocytic	NULL
differentiation	NULL
by	NULL
morphology	NULL
,	NULL
F4/80	NULL
,	NULL
and	NULL
Mac3	NULL
surface	NULL
expression	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
after	NULL
3	NULL
days	NULL
of	NULL
incubation	NULL
with	NULL
GM-CSF	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
wild	NULL
type	NULL
GM-CSFRa	NULL
or	NULL
P357G	NULL
showed	NULL
characteristic	NULL
morphology	NULL
of	NULL
monocytic	NULL
lineage	NULL
:	NULL
larger	NULL
cell	NULL
sizes	NULL
,	NULL
fine-stranded	NULL
nuclear	NULL
appearance	NULL
,	NULL
and	NULL
a	NULL
variable	NULL
number	NULL
of	NULL
cytoplasmic	NULL
vacuoles	NULL
.	NULL

Both	NULL
the	NULL
morphologic	NULL
and	NULL
cell	NULL
surfaces	NULL
changes	NULL
induced	NULL
by	NULL
hGM-CSF	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
induced	NULL
by	NULL
mGM-CSF	NULL
treatment	NULL
.	NULL

They	NULL
also	NULL
showed	NULL
increased	NULL
surface	NULL
expression	NULL
of	NULL
F4/80	NULL
and	NULL
Mac3	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

None	NULL
of	NULL
the	NULL
clones	NULL
containing	NULL
terl	NULL
,	NULL
dell	NULL
,	NULL
del2	NULL
,	NULL
del3	NULL
,	NULL
P358G	NULL
,	NULL
or	NULL
P360G	NULL
was	NULL
able	NULL
to	NULL
differentiate	NULL
when	NULL
incubated	NULL
with	NULL
hGM-CSF	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
10	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
all	NULL
ter8	NULL
clones	NULL
that	NULL
were	NULL
derived	NULL
(	NULL
five	NULL
independent	NULL
clones	NULL
)	NULL
differentiated	NULL
as	NULL
well	NULL
as	NULL
wild	NULL
type	NULL
clones	NULL
in	NULL
response	NULL
to	NULL
hGM-CSF	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
10	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
GM-CSF	NULL
receptor	NULL
signals	NULL
by	NULL
ligand-mediated	NULL
het-erodimerization	NULL
of	NULL
GM-CSFRa	NULL
and	NULL
GM-CSFR	NULL
$	NULL
.	NULL

Although	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
GM-CSFRa	NULL
is	NULL
only	NULL
54	NULL
amino	NULL
acids	NULL
,	NULL
this	NULL
short	NULL
region	NULL
of	NULL
the	NULL
receptor	NULL
is	NULL
necessary	NULL
for	NULL
GM-CSF-induced	NULL
cell	NULL
proliferation	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
compared	NULL
the	NULL
role	NULL
of	NULL
GM-CSFRa	NULL
cytoplasmic	NULL
domain	NULL
in	NULL
GM-CSF-mediated	NULL
cell	NULL
proliferation	NULL
,	NULL
survival	NULL
,	NULL
and	NULL
differentiation	NULL
.	NULL

This	NULL
analysis	NULL
was	NULL
made	NULL
possible	NULL
by	NULL
our	NULL
use	NULL
of	NULL
the	NULL
WT19Q	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
grows	NULL
but	NULL
does	NULL
not	NULL
differentiate	NULL
in	NULL
mIL-3	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
mGM-CSF	NULL
induces	NULL
differentiation	NULL
,	NULL
but	NULL
does	NULL
not	NULL
stop	NULL
the	NULL
growth	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

Our	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
P357G	NULL
P358G	NULL
P360G	NULL
-	NULL
ter3	NULL
del3	NULL
del	NULL
-	NULL
del2	NULL
$	NULL
008	NULL
4008	NULL
#	NULL
0	NULL
-	NULL
og	NULL
-~	NULL
+	NULL
-p52Shc	NULL
aShc	NULL
--	NULL
--	NULL
...	NULL
...	NULL
Oi	NULL
--	NULL
wo	NULL
ww	NULL
»	NULL
to	NULL
OD	NULL
Oh	NULL
-o	NULL
525SN	NULL
c	NULL
blot	NULL
®	NULL
»	NULL
sm	NULL
mom	NULL
gos	NULL
#	NULL
#	NULL
H	NULL
#	NULL
#	NULL
H0P	NULL
#	NULL
#	NULL
#	NULL
#	NULL
B	NULL
aJAK2	NULL
IP	NULL
#	NULL
#	NULL
(	NULL
aP-Tyr	NULL
blot	NULL
wap	NULL
wam	NULL
#	NULL
B	NULL
@	NULL
-p46Shc	NULL
-JAK2	NULL
cJAK2	NULL
Winqae	NULL
gap	NULL
wib	NULL
aw	NULL
we	NULL
wo	NULL
ao	NULL
oe	NULL
on	NULL
win	NULL
yl	NULL
oms	NULL
om	NULL
am	NULL
cam	NULL
an	NULL
wae	NULL
-	NULL
J	NULL
AK	NULL
2	NULL
blot	NULL
C	NULL
aStat5	NULL
IP	NULL
Ce	NULL
vep	NULL
aP-Tyr	NULL
blot	NULL
aStat5	NULL
blot	NULL
~Stat5	NULL
i	NULL
»	NULL
us	NULL
use	NULL
¥	NULL
!	NULL

as	NULL
®	NULL
an	NULL
on	NULL
th	NULL
th	NULL
Oh	NULL
O	NULL
Uh	NULL
ts	NULL
th	NULL
ts	NULL
as	NULL
a	NULL
S	NULL
>	NULL
Fic	NULL
.	NULL

5.	NULL
hGM-CSF-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
signaling	NULL
molecules	NULL
in	NULL
WT19	NULL
transfectants	NULL
.	NULL

WT19	NULL
cells	NULL
expressing	NULL
the	NULL
wild-type	NULL
subunit	NULL
and	NULL
the	NULL
indicated	NULL
GM-CSFRa	NULL
construct	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
10	NULL
ng/ml	NULL
hGM-CSF	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
appropriate	NULL
antibody	NULL
,	NULL
and	NULL
the	NULL
immunoprecipitates	NULL
were	NULL
run	NULL
on	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
Western	NULL
blot	NULL
was	NULL
then	NULL
carried	NULL
out	NULL
.	NULL

A	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
She	NULL
in	NULL
response	NULL
to	NULL
hGM-CSF	NULL
in	NULL
WT19	NULL
transfectants	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-She	NULL
antibody	NULL
,	NULL
and	NULL
the	NULL
Western	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
antibody	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
anti-She	NULL
antibody	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
in	NULL
response	NULL
to	NULL
hGM-CSF	NULL
in	NULL
WT19	NULL
transfectants	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Jak2	NULL
antibody	NULL
,	NULL
and	NULL
the	NULL
immunoblot	NULL
was	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
antibody	NULL
(	NULL
upper	NULL
panel	NULL
!	NULL
)	NULL

or	NULL
anti-JAK2	NULL
antibody	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

C	NULL
,	NULL
hGM-CSF-dependent	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STATS5	NULL
antibody	NULL
and	NULL
immunoblotted	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
antibody	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
anti-STAT5	NULL
antibody	NULL
(	NULL
Zower	NULL
panel	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
17456	NULL
teri	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
c-myc	NULL
C	NULL
I	NULL
_J	NULL
c-fos	NULL
®	NULL
&	NULL
c-jun	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Induction	NULL
of	NULL
nuclear	NULL
proto-oncogenes	NULL
in	NULL
WTI19	NULL
transfectants	NULL
.	NULL

Growth	NULL
factor-starved	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
hGM-CSF	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
(	NULL
0	NULL
,	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
or	NULL
2	NULL
h	NULL
)	NULL
.	NULL

Total	NULL
mRNAs	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
were	NULL
electrophoresed	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
transferred	NULL
onto	NULL
nylon	NULL
ter3	NULL
membranes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
prehy-bridized	NULL
,	NULL
hybridized	NULL
with	NULL
radiolabeled	NULL
DNA	NULL
probes	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
x	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
films	NULL
.	NULL

tay	NULL
films	NULL
cmy	NULL
:	NULL
-	NULL
#	NULL
APMD	NULL
c-fos	NULL
c-jun	NULL
#	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
GM-CSFR	NULL
«	NULL
-Chain	NULL
Mediates	NULL
Cell	NULL
Differentiation	NULL
wt	NULL
P357G	NULL
P358G	NULL
P360G	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
0	NULL
0.5	NULL
1	NULL
2h	NULL
eee	NULL
c	NULL
#	NULL
88	NULL
aln	NULL
#	NULL
Swen	NULL
..	NULL
«	NULL
-	NULL
.	NULL

#	NULL
#	NULL
#	NULL
O00	NULL
0000	NULL
#	NULL
#	NULL
#	NULL
®	NULL
dell	NULL
del	NULL
?	NULL

del3	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
0	NULL
0.5	NULL
1	NULL
2h	NULL
L	NULL
mGM-CSF-mediated	NULL
differentiation	NULL
process	NULL
is	NULL
reversible	NULL
upon	NULL
removal	NULL
of	NULL
mGM-CSF	NULL
.	NULL

The	NULL
WTI1Q	NULL
cells	NULL
are	NULL
equally	NULL
capable	NULL
of	NULL
responding	NULL
to	NULL
both	NULL
murine	NULL
and	NULL
human	NULL
GM-CSF	NULL
when	NULL
transfected	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
human	NULL
GM-CSF	NULL
receptor	NULL
subunits	NULL
.	NULL

By	NULL
using	NULL
a	NULL
mutant	NULL
GM-CSF	NULL
Ra	NULL
lacking	NULL
most	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
GM-CSFRa	NULL
is	NULL
essential	NULL
for	NULL
both	NULL
hGM-CSF-dependent	NULL
cell	NULL
differentiation	NULL
and	NULL
proliferation	NULL
.	NULL

This	NULL
mutant	NULL
was	NULL
still	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
-chain	NULL
to	NULL
form	NULL
a	NULL
high	NULL
affinity	NULL
receptor	NULL
complex	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
GM-CSFRa	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
receptor	NULL
dimerization	NULL
.	NULL

The	NULL
GM-CSFRa	NULL
cytoplasmic	NULL
domain	NULL
was	NULL
necessary	NULL
for	NULL
the	NULL
phosphorylation	NULL
of	NULL
signaling	NULL
molecules	NULL
,	NULL
JAK2	NULL
,	NULL
STAT5	NULL
,	NULL
She	NULL
,	NULL
and	NULL
ERKs	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
.	NULL

Weak	NULL
activation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT3	NULL
by	NULL
GM-CSF	NULL
have	NULL
recently	NULL
been	NULL
reported	NULL
in	NULL
polymorphonuclear	NULL
leukocytes	NULL
(	NULL
36	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
could	NULL
not	NULL
detect	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
STAT	NULL
's	NULL
in	NULL
any	NULL
of	NULL
the	NULL
transfectants	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
intracytoplasmic	NULL
domain	NULL
did	NULL
not	NULL
abolish	NULL
e-mye	NULL
mRNA	NULL
induction	NULL
after	NULL
GM-CSF	NULL
stimulation	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
by	NULL
us	NULL
using	NULL
BaF/3	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Using	NULL
other	NULL
cell	NULL
systems	NULL
and	NULL
varying	NULL
approaches	NULL
other	NULL
laboratories	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
internal	NULL
portion	NULL
of	NULL
the	NULL
GM-CSFRa	NULL
may	NULL
not	NULL
have	NULL
a	NULL
major	NULL
role	NULL
in	NULL
regulating	NULL
receptor	NULL
function	NULL
.	NULL

For	NULL
example	NULL
,	NULL
using	NULL
a	NULL
chimera	NULL
of	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
and	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
murine	NULL
IL-3	NULL
receptor	NULL
B	NULL
chain	NULL
(	NULL
AIC2A	NULL
)	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
erythropoietin	NULL
to	NULL
the	NULL
receptor	NULL
was	NULL
able	NULL
to	NULL
stimulate	NULL
cell	NULL
growth	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Another	NULL
study	NULL
demonstrated	NULL
that	NULL
a	NULL
chimera	NULL
comprising	NULL
the	NULL
extracellular	NULL
region	NULL
of	NULL
GM-CSFRa	NULL
and	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
hfe	NULL
can	NULL
also	NULL
transduce	NULL
signals	NULL
(	NULL
38	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
dimerization	NULL
of	NULL
the	NULL
B-chain	NULL
is	NULL
important	NULL
.	NULL

However	NULL
,	NULL
they	NULL
do	NULL
not	NULL
necessarily	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
GM-CSFRa	NULL
is	NULL
an	NULL
important	NULL
dimerization	NULL
partner	NULL
,	NULL
and	NULL
there	NULL
are	NULL
no	NULL
physiologic	NULL
data	NULL
demonstrating	NULL
that	NULL
two	NULL
B	NULL
chains	NULL
dimer	NULL
ize	NULL
to	NULL
initiate	NULL
signaling	NULL
in	NULL
normal	NULL
cells	NULL
.	NULL

Both	NULL
the	NULL
a	NULL
and	NULL
B	NULL
subunits	NULL
have	NULL
proline-rich	NULL
regions	NULL
close	NULL
to	NULL
the	NULL
plasma	NULL
mem-brane	NULL
,	NULL
and	NULL
both	NULL
of	NULL
these	NULL
regions	NULL
are	NULL
important	NULL
for	NULL
receptor	NULL
function	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
«	NULL
internal	NULL
segment	NULL
blocks	NULL
both	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

By	NULL
using	NULL
deletion	NULL
mutants	NULL
of	NULL
GM-CSFa	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
membrane	NULL
proximal	NULL
proline-rich	NULL
region	NULL
and	NULL
the	NULL
adjacent	NULL
15	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
a	NULL
subunit	NULL
are	NULL
indispensable	NULL
for	NULL
both	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
proline-rich	NULL
region	NULL
of	NULL
GM-CSFRa	NULL
contains	NULL
a	NULL
Pro-X-Pro	NULL
sequence	NULL
that	NULL
exists	NULL
in	NULL
the	NULL
membrane-proximal	NULL
box1l	NULL
region	NULL
of	NULL
many	NULL
other	NULL
members	NULL
of	NULL
cytokine	NULL
receptors	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
this	NULL
domain	NULL
in	NULL
the	NULL
IL6	NULL
receptor	NULL
gp130	NULL
protein	NULL
(	NULL
39	NULL
)	NULL
and	NULL
in	NULL
the	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
(	NULL
40	NULL
)	NULL
eliminated	NULL
receptor	NULL
activity	NULL
.	NULL

We	NULL
have	NULL
here	NULL
shown	NULL
that	NULL
similar	NULL
mutations	NULL
(	NULL
P358G	NULL
,	NULL
P360G	NULL
)	NULL
also	NULL
result	NULL
in	NULL
a	NULL
receptor	NULL
that	NULL
is	NULL
unable	NULL
to	NULL
mediate	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
or	NULL
other	NULL
signaling	NULL
events	NULL
.	NULL

Proline	NULL
357	NULL
could	NULL
be	NULL
part	NULL
of	NULL
a	NULL
Pro-X-X-Pro	NULL
motif	NULL
,	NULL
such	NULL
as	NULL
has	NULL
also	NULL
been	NULL
found	NULL
in	NULL
cytokine	NULL
receptors	NULL
and	NULL
SH3-binding	NULL
proteins	NULL
(	NULL
41	NULL
)	NULL
.	NULL

This	NULL
proline	NULL
appears	NULL
to	NULL
be	NULL
dispensable	NULL
,	NULL
however	NULL
,	NULL
since	NULL
the	NULL
P357G	NULL
mutant	NULL
was	NULL
able	NULL
to	NULL
fully	NULL
support	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

The	NULL
region	NULL
downstream	NULL
from	NULL
the	NULL
proline-rich	NULL
domain	NULL
was	NULL
also	NULL
indispensable	NULL
for	NULL
hGM-CSF-dependent	NULL
transduction	NULL
of	NULL
cell	NULL
growth	NULL
,	NULL
survival	NULL
,	NULL
and	NULL
differentiation	NULL
signals	NULL
.	NULL

These	NULL
15	NULL
amino	NULL
acid	NULL
residues	NULL
,	NULL
which	NULL
include	NULL
aspartic	NULL
acid	NULL
368	NULL
,	NULL
are	NULL
conserved	NULL
in	NULL
ILG	NULL
receptor	NULL
a	NULL
,	NULL
prolactin	NULL
receptor	NULL
,	NULL
growth	NULL
hormone	NULL
receptor	NULL
,	NULL
and	NULL
IL2	NULL
receptor	NULL
y-chain	NULL
.	NULL

Our	NULL
studies	NULL
show	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
and	NULL
STATS	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
deletion	NULL
of	NULL
this	NULL
region	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
proline-rich	NULL
domain	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
the	NULL
GM-CSF-induced	NULL
activation	NULL
of	NULL
the	NULL
JAK2	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
in	NULL
other	NULL
systems	NULL
.	NULL

Deletion	NULL
of	NULL
6	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
region	NULL
downstream	NULL
of	NULL
proline-rich	NULL
domain	NULL
of	NULL
IL5	NULL
receptor	NULL
a	NULL
,	NULL
including	NULL
the	NULL
conserved	NULL
aspartic	NULL
acid	NULL
,	NULL
abolished	NULL
IL5-induced	NULL
JAK2	NULL
acti-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GM-CSFR	NULL
«	NULL
-Chain	NULL
Mediates	NULL
Cell	NULL
Differentiation	NULL
100	NULL
100	NULL
$	NULL
alone	NULL
PARENTAL	NULL
-a-	NULL
GM	NULL
:	NULL
clone	NULL
1	NULL
#	NULL
GM	NULL
:	NULL
clone	NULL
2	NULL
-	NULL
3	NULL
1	NULL
a	NULL
3	NULL
i	NULL
f	NULL
01-7	NULL
t	NULL
0.17	NULL
-4-	NULL
GM	NULL
:	NULL
clone	NULL
3	NULL
-+-	NULL
mils	NULL
0.01	NULL
c.01	NULL
1-9	NULL
day0	NULL
day1	NULL
day2	NULL
days	NULL
days	NULL
dayO	NULL
day	NULL
?	NULL

day2	NULL
days	NULL
day4	NULL
100	NULL
100	NULL
100	NULL
wild	NULL
type	NULL
teri	NULL
0.14	NULL
e	NULL
a	NULL
8	NULL
T	NULL
I	NULL
0.01	NULL
0.01	NULL
Tororo	NULL
gat	NULL
dayO	NULL
day1	NULL
day	NULL
?	NULL

days	NULL
day4	NULL
day0	NULL
day1	NULL
day	NULL
?	NULL

days	NULL
day4	NULL
dayO	NULL
day	NULL
!	NULL

day	NULL
?	NULL

days	NULL
day4	NULL
100	NULL
100	NULL
dell	NULL
12	NULL
del3	NULL
0.1	NULL
0.1	NULL
~	NULL
017	NULL
-	NULL
3	NULL
|	NULL
com	NULL
.	NULL

accra	NULL
or	NULL
ran	NULL
_	NULL
3	NULL
i	NULL
al	NULL
a	NULL
3	NULL
u	NULL
1	NULL
0.01	NULL
0.01	NULL
0.01	NULL
T	NULL
T	NULL
U	NULL
I	NULL
day0	NULL
day1	NULL
day	NULL
?	NULL

day3	NULL
dayd	NULL
day1	NULL
day2	NULL
day3	NULL
day4	NULL
day	NULL
day1	NULL
day	NULL
?	NULL

days	NULL
day4	NULL
100	NULL
100	NULL
100	NULL
58G	NULL
P360G	NULL
0.17	NULL
0.14	NULL
0.17	NULL
3	NULL
9	NULL
[	NULL
od	NULL
/\8	NULL
0.01	NULL
0.01	NULL
dayO	NULL
day	NULL
?	NULL

day2	NULL
days	NULL
day4	NULL
day	NULL
day1	NULL
day	NULL
?	NULL

days	NULL
day4	NULL
dayO	NULL
day	NULL
?	NULL

day	NULL
?	NULL

day3	NULL
day4	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Growth	NULL
response	NULL
of	NULL
transfectants	NULL
and	NULL
parental	NULL
WT19	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
in	NULL
10	NULL
ng/m	NULL
!	NULL

of	NULL
either	NULL
mIL8	NULL
or	NULL
hGM-CSF	NULL
.	NULL

At	NULL
the	NULL
times	NULL
indicated	NULL
,	NULL
the	NULL
number	NULL
of	NULL
viable	NULL
cells	NULL
in	NULL
each	NULL
culture	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
staining	NULL
.	NULL

The	NULL
results	NULL
were	NULL
expressed	NULL
relative	NULL
to	NULL
the	NULL
cell	NULL
number	NULL
on	NULL
day	NULL
0	NULL
of	NULL
this	NULL
experiment	NULL
.	NULL

Three	NULL
independent	NULL
clones	NULL
of	NULL
each	NULL
cell	NULL
type	NULL
were	NULL
assayed	NULL
yielding	NULL
similar	NULL
results	NULL
.	NULL

The	NULL
average	NULL
value	NULL
of	NULL
the	NULL
three	NULL
clones	NULL
was	NULL
shown	NULL
for	NULL
mIL8	NULL
responses	NULL
.	NULL

vation	NULL
(	NULL
42	NULL
)	NULL
,	NULL
while	NULL
mutation	NULL
of	NULL
the	NULL
region	NULL
immediately	NULL
downstream	NULL
of	NULL
box1l	NULL
region	NULL
in	NULL
the	NULL
erythropoietin	NULL
(	NULL
43	NULL
)	NULL
and	NULL
IL6	NULL
receptors	NULL
(	NULL
39	NULL
)	NULL
blocked	NULL
the	NULL
activation	NULL
of	NULL
JAK2	NULL
.	NULL

Interestingly	NULL
,	NULL
our	NULL
data	NULL
about	NULL
proline	NULL
mutations	NULL
in	NULL
the	NULL
box1l	NULL
region	NULL
were	NULL
different	NULL
from	NULL
the	NULL
recently	NULL
published	NULL
study	NULL
on	NULL
the	NULL
IL-5	NULL
receptor	NULL
«	NULL
-chain	NULL
.	NULL

In	NULL
the	NULL
previous	NULL
report	NULL
,	NULL
the	NULL
existence	NULL
of	NULL
any	NULL
one	NULL
of	NULL
the	NULL
three	NULL
proline	NULL
residues	NULL
was	NULL
adequate	NULL
for	NULL
IL-5-mediated	NULL
cell	NULL
proliferation	NULL
signal	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
these	NULL
findings	NULL
could	NULL
be	NULL
secondary	NULL
to	NULL
differences	NULL
in	NULL
sequence	NULL
in	NULL
the	NULL
a-chains	NULL
(	NULL
PPVPQI	NULL
,	NULL
GM-CSF	NULL
receptor	NULL
;	NULL
PPIPAP	NULL
,	NULL
IL-5	NULL
recep-tor	NULL
)	NULL
,	NULL
or	NULL
,	NULL
possibly	NULL
the	NULL
difference	NULL
in	NULL
results	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
divergence	NULL
in	NULL
amino	NULL
acid	NULL
residues	NULL
adjacent	NULL
to	NULL
the	NULL
proline-rich	NULL
domain	NULL
.	NULL

The	NULL
C-terminal	NULL
deletion	NULL
of	NULL
GM-CSFRa	NULL
only	NULL
partially	NULL
inhibited	NULL
the	NULL
hGM-CSF	NULL
-induced	NULL
cell	NULL
proliferation	NULL
(	NULL
Figs	NULL
.	NULL

7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
but	NULL
the	NULL
cells	NULL
died	NULL
within	NULL
several	NULL
days	NULL
due	NULL
to	NULL
the	NULL
extensive	NULL
apoptosis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hGM-CSF	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

In	NULL
the	NULL
transfectants	NULL
of	NULL
this	NULL
C-terminal	NULL
deletion	NULL
mutant	NULL
(	NULL
ter3	NULL
)	NULL
,	NULL
hGM-CSF-induced	NULL
protein-tyrosine	NULL
phosphorylation	NULL
was	NULL
severely	NULL
impaired	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
52-kDa	NULL
protein	NULL
,	NULL
Shc	NULL
,	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
stimulation	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
27-30	NULL
,	NULL
17457	NULL
on4ago	NULL
-	NULL
**	NULL
z	NULL
z	NULL
03	NULL
4	NULL
-+-	NULL
P3STG	NULL
0.25	NULL
7	NULL
-A-	NULL
ters	NULL
0.27	NULL
-e-	NULL
tert	NULL
0154	NULL
0.1	NULL
4	NULL
0.054	NULL
04	NULL
0.054	NULL
y	NULL
7	NULL
r	NULL
.	NULL

o	NULL
0.02	NULL
02	NULL
o	NULL
20	NULL
hGM-CSF	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

Fic	NULL
.	NULL

8	NULL
.	NULL

MTS	NULL
proliferation	NULL
assay	NULL
of	NULL
three	NULL
WTI1Q	NULL
transfectants	NULL
and	NULL
parental	NULL
WT19	NULL
cells	NULL
.	NULL

Cells	NULL
(	NULL
5,000	NULL
cells/each	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
various	NULL
concentrations	NULL
of	NULL
GM-CSF	NULL
for	NULL
14	NULL
h	NULL
at	NULL
87°C	NULL
.	NULL

After	NULL
MTS/PMS	NULL
solution	NULL
was	NULL
added	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

The	NULL
conversion	NULL
of	NULL
MTS	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
amount	NULL
of	NULL
490	NULL
nm	NULL
absorbance	NULL
.	NULL

Error	NULL
bars	NULL
from	NULL
triplicate	NULL
experiments	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

teri	NULL
WT	NULL
ter3	NULL
0	NULL
9	NULL
24	NULL
0	NULL
9	NULL
24	NULL
0	NULL
9	NULL
24	NULL
hr	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
C-terminal	NULL
deletion	NULL
on	NULL
the	NULL
anti-apoptotic	NULL
function	NULL
of	NULL
hGM-CSF	NULL
.	NULL

Three	NULL
WT19	NULL
transfectants	NULL
were	NULL
washed	NULL
with	NULL
factor-free	NULL
medium	NULL
and	NULL
incubated	NULL
in	NULL
medium	NULL
containing	NULL
10	NULL
ng/ml	NULL
hGM-CSF	NULL
for	NULL
indicated	NULL
time	NULL
.	NULL

Total	NULL
cellular	NULL
DNA	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
1.8	NULL
%	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Sizes	NULL
of	NULL
DNA	NULL
markers	NULL
are	NULL
indicated	NULL
.	NULL

44	NULL
)	NULL
.	NULL

She	NULL
,	NULL
when	NULL
tyrosine-phosphorylated	NULL
,	NULL
binds	NULL
to	NULL
SH2	NULL
domains	NULL
of	NULL
Grb2	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
the	NULL
recruitment	NULL
of	NULL
Sos	NULL
,	NULL
a	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
factor	NULL
for	NULL
Ras	NULL
,	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
She	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
GM-CSF-mediated	NULL
activation	NULL
of	NULL
Ras	NULL
through	NULL
this	NULL
mechanism	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
ter3	NULL
transfectants	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
She	NULL
was	NULL
not	NULL
detectable	NULL
in	NULL
response	NULL
to	NULL
hGM-CSF	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

hGM-CSF-induced	NULL
activation	NULL
of	NULL
Ras-ERK	NULL
pathway	NULL
appeared	NULL
to	NULL
be	NULL
impaired	NULL
in	NULL
these	NULL
transfectants	NULL
,	NULL
since	NULL
hGM-CSF-mediated	NULL
ERK	NULL
phosphorylation	NULL
and	NULL
c-fos	NULL
in-duction	NULL
,	NULL
which	NULL
are	NULL
downstream	NULL
events	NULL
regulated	NULL
by	NULL
Ras	NULL
activation	NULL
(	NULL
46	NULL
,	NULL
47	NULL
)	NULL
,	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
are	NULL
compatible	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
that	NULL
Ras	NULL
activation	NULL
is	NULL
necessary	NULL
for	NULL
anti-apoptotic	NULL
effect	NULL
by	NULL
GM-CSF	NULL
,	NULL
but	NULL
not	NULL
essential	NULL
for	NULL
GM-CSF-mediated	NULL
DNA	NULL
synthesis	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
ter3	NULL
transfectants	NULL
differentiated	NULL
as	NULL
well	NULL
as	NULL
wild	NULL
type	NULL
transfectants	NULL
in	NULL
response	NULL
to	NULL
hGM-CSF	NULL
.	NULL

The	NULL
ter3	NULL
clones	NULL
are	NULL
capable	NULL
of	NULL
stimulating	NULL
increases	NULL
in	NULL
e-mye	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
c-jun	NULL
,	NULL
but	NULL
do	NULL
not	NULL
cause	NULL
the	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
,	NULL
STAT	NULL
,	NULL
and	NULL
She	NULL
,	NULL
suggesting	NULL
that	NULL
activation	NULL
of	NULL
these	NULL
proteins	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
differentiation	NULL
.	NULL

The	NULL
findings	NULL
that	NULL
ter3	NULL
cells	NULL
die	NULL
of	NULL
apoptosis	NULL
while	NULL
they	NULL
were	NULL
capable	NULL
of	NULL
differentiation	NULL
in	NULL
hGM-CSF	NULL
suggests	NULL
that	NULL
the	NULL
pathways	NULL
controlling	NULL
cell	NULL
survival	NULL
and	NULL
differentiation	NULL
can	NULL
be	NULL
separated	NULL
and	NULL
are	NULL
controlled	NULL
by	NULL
different	NULL
portions	NULL
of	NULL
the	NULL
GM-CSFRa	NULL
.	NULL

hGM-CSF-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
and	NULL
STATS5	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
ter8	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
pathways	NULL
may	NULL
be	NULL
important	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
expression	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
17458	NULL
GM-CSFR	NULL
«	NULL
-Chain	NULL
Mediates	NULL
Cell	NULL
Differentiation	NULL
parental	NULL
teri	NULL
2000	NULL
,	NULL
6	NULL
.	NULL

1	NULL
f	NULL
S	NULL
“	NULL
;	NULL
Q.Q	NULL
;	NULL
&	NULL
d	NULL
w	NULL
}	NULL
Fic	NULL
.	NULL

10	NULL
.	NULL

Morphological	NULL
changes	NULL
of	NULL
WTI9	NULL
transfectants	NULL
in	NULL
response	NULL
to	NULL
hGM-CSF	NULL
.	NULL

WT19	NULL
GM-CSFRa	NULL
transfectants	NULL
were	NULL
maintained	NULL
in	NULL
mIL3	NULL
alone	NULL
or	NULL
mIL3	NULL
+	NULL
10	NULL
ng/ml	NULL
hGM-CSF	NULL
.	NULL

Wright	NULL
staining	NULL
was	NULL
performed	NULL
(	NULL
original	NULL
magnifi-cation	NULL
,	NULL
X400	NULL
)	NULL
on	NULL
day	NULL
3	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
parental	NULL
WT19	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
mIL3	NULL
or	NULL
mIL3	NULL
+	NULL
10	NULL
ng/ml	NULL
mGM-CSF	NULL
.	NULL

of	NULL
a	NULL
chimeric	NULL
protein	NULL
of	NULL
CD16	NULL
and	NULL
Jak2	NULL
is	NULL
capable	NULL
of	NULL
preventing	NULL
cell	NULL
death	NULL
,	NULL
implying	NULL
that	NULL
part	NULL
of	NULL
the	NULL
function	NULL
of	NULL
the	NULL
Jak/STAT	NULL
pathway	NULL
could	NULL
be	NULL
to	NULL
inhibit	NULL
apoptosis	NULL
(	NULL
51	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
other	NULL
signal	NULL
transduction	NULL
pathways	NULL
,	NULL
both	NULL
c-mye	NULL
and	NULL
c-jun	NULL
were	NULL
induced	NULL
in	NULL
ter3	NULL
transfectants	NULL
by	NULL
hGM-CSF	NULL
to	NULL
similar	NULL
levels	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
wild	NULL
type	NULL
transfectants	NULL
,	NULL
suggesting	NULL
that	NULL
e-mye	NULL
and	NULL
c-jun	NULL
can	NULL
be	NULL
induced	NULL
without	NULL
the	NULL
activation	NULL
of	NULL
either	NULL
ERKs	NULL
or	NULL
JAK2	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
report	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
the	NULL
transient	NULL
expression	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
JAK2	NULL
inhibited	NULL
hGM-CSF-induced	NULL
transcription	NULL
of	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
c-mye	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
JAK2	NULL
is	NULL
essential	NULL
for	NULL
c-mye	NULL
mRNA	NULL
induction	NULL
by	NULL
hGM-CSF	NULL
(	NULL
48	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
inhibition	NULL
of	NULL
e-mye	NULL
promoter	NULL
was	NULL
caused	NULL
by	NULL
a	NULL
nonspecific	NULL
effect	NULL
of	NULL
the	NULL
overexpression	NULL
of	NULL
dominant-negative	NULL
JAK2	NULL
,	NULL
although	NULL
further	NULL
experiments	NULL
will	NULL
be	NULL
needed	NULL
to	NULL
clarify	NULL
this	NULL
possibility	NULL
.	NULL

c-jun	NULL
overexpression	NULL
induces	NULL
monocytic	NULL
differentiation	NULL
of	NULL
the	NULL
WEHI-3B	NULL
(	NULL
49	NULL
)	NULL
and	NULL
U937	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
,	NULL
while	NULL
c-fos	NULL
overexpression	NULL
did	NULL
not	NULL
have	NULL
similar	NULL
biologic	NULL
effects	NULL
(	NULL
49	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
c-jun	NULL
alone	NULL
is	NULL
responsible	NULL
for	NULL
hGM-CSF-mediated	NULL
cell	NULL
differentiation	NULL
,	NULL
as	NULL
c-jun	NULL
mRNA	NULL
expression	NULL
was	NULL
equivalently	NULL
induced	NULL
by	NULL
mIL3	NULL
,	NULL
which	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
differentiated	NULL
phenotype	NULL
of	NULL
WTI1Q	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
specific	NULL
regions	NULL
of	NULL
the	NULL
intracytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
a	NULL
subunit	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
hGM-CSF-mediated	NULL
cell	NULL
proliferation	NULL
,	NULL
survival	NULL
,	NULL
and	NULL
differentiation	NULL
,	NULL
while	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
which	NULL
controls	NULL
e-mye	NULL
activation	NULL
is	NULL
inde-	NULL
P	NULL
|	NULL
%	NULL
.	NULL

®	NULL
?	NULL

Q	NULL
.	NULL

%	NULL
if	NULL
}	NULL
:	NULL
#	NULL
#	NULL
,	NULL
mGM	NULL
mIL3	NULL
hGM	NULL
pendent	NULL
of	NULL
this	NULL
subunit	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
differentiation	NULL
may	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
She	NULL
,	NULL
ERK	NULL
,	NULL
or	NULL
JAK2	NULL
activation	NULL
,	NULL
suggesting	NULL
that	NULL
there	NULL
are	NULL
specific	NULL
novel	NULL
signal	NULL
transduction	NULL
pathways	NULL
,	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
,	NULL
which	NULL
control	NULL
this	NULL
process	NULL
.	NULL

REFERENCES	NULL
.	NULL

Baldwin	NULL
,	NULL
G.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

151	NULL
,	NULL
352-367	NULL
2	NULL
.	NULL

Crosier	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
Mathey-Prevot	NULL
,	NULL
B.	NULL
,	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
and	NULL
Sieff	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7744-7748	NULL
3	NULL
.	NULL

Gough	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
Gough	NULL
,	NULL
J.	NULL
,	NULL
Metcalf	NULL
,	NULL
D.	NULL
,	NULL
Kelso	NULL
,	NULL
A.	NULL
,	NULL
Grail	NULL
,	NULL
D.	NULL
,	NULL
Nicola	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Burgess	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
809	NULL
,	NULL
768-767	NULL
4	NULL
.	NULL

Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
Witek	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Temple	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Wilkens	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Leary	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Luxenburg	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Jones	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Brown	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
Kay	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Ort	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Shoemaker	NULL
,	NULL
C.	NULL
,	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Kaufman	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Hewick	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
228	NULL
,	NULL
810-815	NULL
5	NULL
.	NULL

Gasson	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1131-1145	NULL
6	NULL
.	NULL

Tomonaga	NULL
,	NULL
M.	NULL
,	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
Blood	NULL
67	NULL
,	NULL
81-86	NULL
7	NULL
.	NULL

Emerson	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Thomas	NULL
,	NULL
S.	NULL
,	NULL
Ferrara	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Greenstein	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
49-55	NULL
.	NULL

8	NULL
.	NULL

Sieff	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Emerson	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Donahue	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Nathan	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Wang	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
and	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
280	NULL
,	NULL
1171-1173	NULL
9	NULL
.	NULL

Till	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Burthem	NULL
,	NULL
J.	NULL
,	NULL
Lopez	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Cowley	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
88	NULL
,	NULL
479-486	NULL
10	NULL
.	NULL

Gearing	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
King	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Gough	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
and	NULL
Nicola	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
3667-3676	NULL
11	NULL
.	NULL

Hayashida	NULL
,	NULL
K.	NULL
,	NULL
Kitamura	NULL
,	NULL
T.	NULL
,	NULL
Gorman	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Arai	NULL
,	NULL
T.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9655-9659	NULL
12	NULL
.	NULL

Ashworth	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
7178	NULL
13	NULL
.	NULL

Raines	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Liu	NULL
,	NULL
L.	NULL
,	NULL
Quan	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Joe	NULL
,	NULL
Y.	NULL
,	NULL
DiPersio	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
8208-8207	NULL
14	NULL
.	NULL

Kitamura	NULL
,	NULL
T.	NULL
,	NULL
Sato	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
1165-1174	NULL
15	NULL
.	NULL

Tavernier	NULL
,	NULL
J.	NULL
,	NULL
Devos	NULL
,	NULL
R.	NULL
,	NULL
Cornelis	NULL
,	NULL
S.	NULL
,	NULL
Tuypens	NULL
,	NULL
T.	NULL
,	NULL
Heyden	NULL
,	NULL
J.	NULL
V.	NULL
D.	NULL
,	NULL
Fiers	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Plactinck	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
1175-1184	NULL
16	NULL
.	NULL

Polotskaya	NULL
,	NULL
A.	NULL
,	NULL
Zhao	NULL
,	NULL
Y.	NULL
,	NULL
Lilly	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
Growth	NULL
Diff	NULL
.	NULL

a	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32.	NULL
.	NULL

Mui	NULL
,	NULL
A.	NULL
L.-F.	NULL
,	NULL
Wakao	NULL
,	NULL
H.	NULL
,	NULL
O'Farrell	NULL
,	NULL
A.-M.	NULL
,	NULL
Harada	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
GM-CSFR	NULL
«	NULL
-Chain	NULL
Mediates	NULL
Cell	NULL
Differentiation	NULL
4	NULL
,	NULL
528-531	NULL
Polotskaya	NULL
,	NULL
A.	NULL
,	NULL
Zhao	NULL
,	NULL
Y.	NULL
,	NULL
Lilly	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
14607-14613	NULL
Weiss	NULL
,	NULL
M.	NULL
,	NULL
Yokoyama	NULL
,	NULL
C.	NULL
,	NULL
Shikama	NULL
,	NULL
Y.	NULL
,	NULL
Naugle	NULL
,	NULL
C.	NULL
,	NULL
Druker	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Sicff	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
3298-3306	NULL
Sakamaki	NULL
,	NULL
K.	NULL
,	NULL
Miyajima	NULL
,	NULL
I.	NULL
,	NULL
Kitamura	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
3541-3549	NULL
Bourette	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Myles	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Carlberg	NULL
,	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
and	NULL
Rohrschneider	NULL
,	NULL
L.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
Growth	NULL
Diff	NULL
.	NULL

6	NULL
,	NULL
631-645	NULL
Dexter	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Garland	NULL
,	NULL
I.	NULL
,	NULL
Scott	NULL
,	NULL
D.	NULL
,	NULL
Scolnick	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Metcalf	NULL
,	NULL
D.	NULL
(	NULL
1980	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

152	NULL
,	NULL
1026-1047	NULL
Park	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Friend	NULL
,	NULL
D.	NULL
,	NULL
Gillis	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Urdal	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

261	NULL
,	NULL
4177-4183	NULL
Austyn	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Gordon	NULL
,	NULL
S.	NULL
(	NULL
1981	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

11	NULL
,	NULL
805-815	NULL
Ho	NULL
,	NULL
M.-K.	NULL
,	NULL
and	NULL
Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

258	NULL
,	NULL
686-642	NULL
McKnight	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Macfarlane	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Dri	NULL
,	NULL
P.	NULL
,	NULL
Turley	NULL
,	NULL
L.	NULL
,	NULL
Willis	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Gordon	NULL
,	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
486-489	NULL
Itoh	NULL
,	NULL
T.	NULL
,	NULL
Muto	NULL
,	NULL
A.	NULL
,	NULL
Watanabe	NULL
,	NULL
S.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
1587-7592	NULL
Kinoshita	NULL
,	NULL
T.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
266-275	NULL
Matsuguchi	NULL
,	NULL
T.	NULL
,	NULL
Salgia	NULL
,	NULL
R.	NULL
,	NULL
Hallek	NULL
,	NULL
M.	NULL
,	NULL
Eder	NULL
,	NULL
M.	NULL
,	NULL
Druker	NULL
,	NULL
B.	NULL
,	NULL
Ernst	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
5016-5021	NULL
Sato	NULL
,	NULL
N.	NULL
,	NULL
Sakamaki	NULL
,	NULL
K.	NULL
,	NULL
Terada	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
4181-4189	NULL
Welham	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Duronio	NULL
,	NULL
V.	NULL
,	NULL
Leslie	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
Bowtell	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Schrader	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
21165-21176	NULL
Egan	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Weinberg	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
19983	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
781-783	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
1415-1421	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
1166-1175	NULL
34	NULL
35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

17459	NULL
.	NULL

Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Sato	NULL
,	NULL
N.	NULL
,	NULL
Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Inhorn	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Eder	NULL
,	NULL
M.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4835-4341	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Watanabe	NULL
,	NULL
S.	NULL
,	NULL
Mui	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Muto	NULL
,	NULL
A.	NULL
,	NULL
Mitajima	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Leukemia	NULL
7	NULL
,	NULL
Suppl	NULL
.	NULL

2	NULL
,	NULL
$	NULL
102-8107	NULL
Brizzi	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Aronica	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Rosso	NULL
,	NULL
A.	NULL
,	NULL
Bagnara	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Yarden	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Pegoraro	NULL
,	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
3562-3567	NULL
Sakamaki	NULL
,	NULL
K.	NULL
,	NULL
Wang	NULL
,	NULL
H.-M.	NULL
,	NULL
Miyajima	NULL
,	NULL
I.	NULL
,	NULL
Kitamura	NULL
,	NULL
T.	NULL
,	NULL
Todokoro	NULL
,	NULL
K.	NULL
,	NULL
Harada	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
15833-15839	NULL
Muto	NULL
,	NULL
A.	NULL
,	NULL
Watanabe	NULL
,	NULL
S.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

208	NULL
,	NULL
368-375	NULL
Murakami	NULL
,	NULL
M.	NULL
,	NULL
Narazaki	NULL
,	NULL
M.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Yawata	NULL
,	NULL
H.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Hamaguchi	NULL
,	NULL
M.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Pro	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
11849-11353	NULL
Fukunaga	NULL
,	NULL
R.	NULL
,	NULL
Ishizaka-Ikeda	NULL
,	NULL
E.	NULL
,	NULL
Pan	NULL
,	NULL
C.-X	NULL
.	NULL

,	NULL
Seto	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nagata	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2855-2865	NULL
Yu	NULL
,	NULL
H.	NULL
,	NULL
Chan	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Feng	NULL
,	NULL
S.	NULL
,	NULL
Dalgarno	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Brauer	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
933-945	NULL
Takaki	NULL
,	NULL
S.	NULL
,	NULL
Kanazawa	NULL
,	NULL
H.	NULL
,	NULL
Shiba	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Takatsu	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
7404-7413	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Yi	NULL
,	NULL
T.	NULL
,	NULL
Tang	NULL
,	NULL
B.	NULL
,	NULL
Miura	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
74	NULL
,	NULL
227-246	NULL
Lanfrancone	NULL
,	NULL
L.	NULL
,	NULL
Pelicci	NULL
,	NULL
G.	NULL
,	NULL
Brizzi	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Aronica	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Casciari	NULL
,	NULL
C.	NULL
,	NULL
Giuli	NULL
,	NULL
S.	NULL
,	NULL
Pegoraro	NULL
,	NULL
L.	NULL
,	NULL
Pawson	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Pelicci	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
10	NULL
,	NULL
907-917	NULL
Boguski	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
and	NULL
McCormick	NULL
,	NULL
F.	NULL
(	NULL
19983	NULL
)	NULL
Nature	NULL
366	NULL
,	NULL
648-653	NULL
De	NULL
Vries-Smith	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Burgering	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
Leevers	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Marshall	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Bos	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
857	NULL
,	NULL
602-604	NULL
Marais	NULL
,	NULL
R.	NULL
,	NULL
Wynne	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Treisman	NULL
,	NULL
R.	NULL
(	NULL
19938	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
381-393	NULL
Watanabe	NULL
,	NULL
S.	NULL
,	NULL
Itoh	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
12681-12686	NULL
Li	NULL
,	NULL
J.	NULL
,	NULL
King	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Sartorelli	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
Growth	NULL
Diff	NULL
.	NULL

5	NULL
,	NULL
748-751	NULL
Szabo	NULL
,	NULL
E.	NULL
,	NULL
Preis	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
Birrer	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
Growth	NULL
Diff	NULL
.	NULL

5	NULL
,	NULL
439-446	NULL
Sakai	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
12350-12358	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
The	NULL
Cytoplasmic	NULL
Domain	NULL
of	NULL
Granulocyte-Macrophage	NULL
Colony	NULL
Factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
Receptor	NULL
o	NULL
Subunit	NULL
Is	NULL
Essential	NULL
for	NULL
Both	NULL
GM-CSF-mediated	NULL
Growth	NULL
and	NULL
Differentiation	NULL
Tetsuya	NULL
Matsuguchi	NULL
,	NULL
Yanming	NULL
Zhao	NULL
,	NULL
Michael	NULL
B.	NULL
Lilly	NULL
and	NULL
Andrew	NULL
S.	NULL
Kraft	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:17450-17459.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.28.17450	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/28/1	NULL
7450	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
50	NULL
references	NULL
,	NULL
29	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
7450	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

